Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 61
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Association between different diet quality scores and depression risk, the REGICOR population-based cohort study

  • Lugon, Gabriela
  • Hernáez, Álvaro|||0000-0001-8593-1477
  • Jacka, F.N.|||0000-0002-9825-0328
  • Marrugat, Jaume|||0000-0003-3320-554X
  • Ramos, Rafel|||0000-0001-7970-5537
  • Garre-Olmo, Josep|||0000-0002-7817-0814
  • Elosua, Roberto|||0000-0001-8235-0095
  • Lassale, Camille|||0000-0002-9340-2708
Our aim was to determine the association between diet quality and depression incidence in the population-based REGICOR cohort study, Catalonia, Spain. Methods: Prospective observational study using participants' baseline (2003-2006), follow-up (2007-2013) and clinical records data. Five diet quality scores were derived from a food frequency questionnaire (FFQ) at baseline: the relative Mediterranean Diet Score (rMED), the Modified Mediterranean Diet Score (ModMDS), a Dietary Approaches to Stop Hypertension (DASH) score, a Healthful Plant-based Diet Index (HPDI) and the World Health Organization Healthy Diet Indicator (WHO-HDI). Participants using pharmacological antidepressant treatment were excluded as a proxy for presence of depression at baseline. At follow-up, the Patient Health Questionnaire (PHQ-9) was applied to assess depressive symptoms (≥ 10 defining depressive disorder). A secondary outcome was depression diagnosis assessed through clinical records. Logistic regression and Cox proportional hazards models were used. Results: Main analysis included 3046 adults (50.3% women) with a mean age of 54.7 (SD = 11.6) years. After 6-years follow-up, 184 (6.04%) cases of depressive disorder were identified. There was 16% lower odds of depressive disorder per 1SD increase of rMED (OR = 0.84; 95%CI = 0.71-0.98). Secondary outcome analysis (n = 4789) identified 261 (5.45%) incident cases of clinical depression diagnosis over 12 years follow-up, and 19% lower risk of clinical depression was observed with the WHO-HDI (HR = 0.81; 95%CI = 0.70-0.93). Adjusting for BMI did not attenuate the findings. Conclusions: A significant inverse association between diet quality and depression incidence was found in this population-based cohort study, independent of sociodemographic, health and lifestyle. Adherence to a healthy diet could be a complementary intervention for the prevention of depression.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Proteostasis disruption and lipid dyshomeostasis in neurodegeneration, exploring common druggable targets across sporadic and monogenic disorders

  • Pereira Sena, Priscila
  • Friedrich, Lea
  • Villarreal, Alcibiades
  • Fath, Florian
  • Sopco, Liubovi
  • Hernandez Guillamon, Maria Mar|||0000-0001-8844-0091
  • Saraiva-Pereira, Maria Luiza
  • Britton, Gabrielle
  • Weber, Jonasz Jeremiasz
  • Schmidt, Thorsten
Neurodegenerative disorders pose an increasing burden in the aging society. These conditions share several molecular pathomechanisms, some of which may offer opportunities for therapeutic intervention. In this review, we explore a representative selection of sporadic and hereditary neurodegenerative diseases-namely Alzheimer's disease, cerebral amyloid angiopathy, and the polyQ disorders spinocerebellar ataxia types 2 and 3, as well as Huntington's disease-which all feature the accumulation of intra- or extracellular protein deposits as a hallmark. We place particular emphasis on dysregulations in proteostasis-underlying the formation of these aggregates-and the less commonly addressed disturbances in lipid metabolism. By highlighting potential mechanistic links across different classes of neurodegenerative diseases, we aim to provide new insights that may guide the identification of shared druggable targets and the development of broad-spectrum therapeutic strategies.
Repisalud
Publication Artículo científico (JournalArticle)

The persistence of low CD4/CD8 ratio in chronic HIV-infection, despite ART suppression and normal CD4 levels, is associated with pre-therapy values of inflammation and thymic function.

  • Garrido-Rodríguez, Vanesa
  • Bulnes-Ramos, Ángel
  • Olivas-Martínez, Israel
  • Pozo-Balado, María Del Mar
  • Álvarez-Ríos, Ana Isabel
  • Gutiérrez, Félix
  • Izquierdo Miguel, Rebeca
  • García, Federico
  • Tiraboschi, Juan Manuel
  • Vera-Méndez, Francisco
  • Peraire, Joaquim
  • Rull, Anna
  • Pacheco, Yolanda María
  • CoRIS Cohort
Background: Persistence of a low CD4/CD8 ratio is associated with an increased morbimortality in people living with HIV (PLWH) under effective antiretroviral therapy. We aimed to explore the immunological significance of a persistently low CD4/CD8 ratio, even despite normal CD4 levels, and assess whether these features vary from those associated to a low nadir-CD4, another well-established predictor of disease progression. Methods: CD4-recovered PLWH were classified by CD4/CD8 ratio after three-years of ART (viral suppression, CD4≥500; R < 0.8, n = 24 and R > 1.2, n = 28). sj/β-TRECs ratio and inflammatory-related markers were quantified. PBMCs were immunophenotyped by CyTOF and functionally characterized by ELISPOT. Subjects were also reclassified depending on nadir-CD4 (N ≤ 350/N > 350). Results: R < 0.8 showed a differential inflammatory profile compared to R > 1.2 (increased β2-microglobulin, D-dimers and IP-10 before ART). R < 0.8 presented lower baseline thymic function, being inversely correlated with post-ART inflammation. R < 0.8 at follow-up showed most alterations in CD8 subsets (increasing frequency and exhibiting a senescent phenotype [e.g., CD57+, CD95+]) and enhanced T-cell IFNγ/IL-2 secretion. However, comparing N ≤ 350 to N > 350, the main features were altered functional markers in CD4 T-cells, despite no differences in maturational subsets, together with a restricted T-cell cytokine secretion pattern. Conclusion: Persistence of low CD4/CD8 ratio in successfully-treated PLWH, with normal CD4 counts, is associated with baseline inflammation and low thymic function, and it features post-therapy alterations specific to CD8 T-cells. Differently, subjects recovered from low nadir-CD4 in this setting feature post-therapy alterations on CD4 T-cells. Hence, different mechanisms of disease progression could underlie these biomarkers, potentially requiring different clinical approaches.
Repisalud
Publication Artículo científico (JournalArticle)

Distribution of Bartonella henselae variants in patients, reservoir hosts and vectors in Spain

  • Gil, Horacio
  • Escudero, Raquel
  • Pons, Inmaculada
  • Rodriguez-Vargas, Manuela
  • Garcia-Esteban, Coral
  • Rodriguez-Moreno, Isabel
  • Garcia-Amil, Cristina
  • Lobo, Bruno
  • Valcárcel, Félix
  • Pérez, Azucena
  • Jiménez, Santos
  • Jado, Isabel
  • Juste, Ramón
  • Segura, Ferrán
  • Anda, Pedro
We have studied the diversity of B. henselae circulating in patients, reservoir hosts and vectors in Spain. In total, we have fully characterized 53 clinical samples from 46 patients, as well as 78 B. henselae isolates obtained from 35 cats from La Rioja and Catalonia (northeastern Spain), four positive cat blood samples from which no isolates were obtained, and three positive fleas by Multiple Locus Sequence Typing and Multiple Locus Variable Number Tandem Repeats Analysis. This study represents the largest series of human cases characterized with these methods, with 10 different sequence types and 41 MLVA profiles. Two of the sequence types and 35 of the profiles were not described previously. Most of the B. henselae variants belonged to ST5. Also, we have identified a common profile (72) which is well distributed in Spain and was found to persist over time. Indeed, this profile seems to be the origin from which most of the variants identified in this study have been generated. In addition, ST5, ST6 and ST9 were found associated with felines, whereas ST1, ST5 and ST8 were the most frequent sequence types found infecting humans. Interestingly, some of the feline associated variants never found on patients were located in a separate clade, which could represent a group of strains less pathogenic for humans.
Repisalud
Publication Artículo científico (JournalArticle)

Evaluation of the SHIGA TOXIN QUIK CHEK after overnight enrichment as screening tool for Shiga toxin-producing Escherichia coli detection in human fecal samples

  • Sanchez-Prieto, Sergio
  • LLorente Rodríguez, Maria Teresa
  • Ramiro-Jimenez, Raquel
  • Herrera-Leon, Laura
  • Herrera-León, Silvia
We evaluated the SHIGA TOXIN QUIK CHEK (STQC) on its suitability for Shiga toxin-producing Escherichia coli (STEC) testing on human fecal samples after overnight enrichment. Our in-house PCR-based protocol for STEC detection was used as the standard for comparison. STQC detected all described Shiga toxin subtypes with the only exception of Stx2f. In comparison to PCR, STQC performed with an overall sensitivity of 55.4%, specificity of 100.0%, positive predictive value of 100.0%, negative predictive value of 73.0%, infinite positive likelihood ratio, and negative likelihood ratio of 0.45. We conclude that STQC may not be considered a suitable screening tool for STEC detection in human fecal samples, although it could be useful for laboratories where PCR is not a routine tool for STEC screening yet, subject to the confirmation of negative samples by a reference laboratory with full diagnostic capabilities.
Repisalud
Publication Artículo científico (JournalArticle)

Kalirin and CHD7: novel endothelial dysfunction indicators in circulating extracellular vesicles from hypertensive patients with albuminuria

  • de la Cuesta, Fernando
  • Baldan-Martin, Montserrat
  • Moreno-Luna, Rafael
  • Alvarez-Llamas, Gloria
  • Gonzalez-Calero, Laura
  • Mourino-Alvarez, Laura
  • Sastre-Oliva, Tamara
  • Lopez, Juan Antonio
  • Vazquez, Jesus
  • Ruiz-Hurtado, Gema
  • Segura, Julian
  • Vivanco, Fernando
  • Ruilope, Luis M
  • Barderas, Maria G
Despite of the great advances in anti-hypertensive therapies, many patients under Renin-Angiotensin-System (RAS) suppression develop albuminuria, which is a clear indicator of therapeutic inefficiency. Hence, indicators of vascular function are needed to assess patients' condition and help deciding future therapies. Proteomic analysis of circulating extracellular vesicles (EVs) showed two proteins, kalirin and chromodomain-helicase-DNA-binding protein 7 (CHD7), increased in albuminuric patients. A positive correlation of both with the expression of the endothelial activation marker E-selectin was found in EVs. In vitro analysis using TNFa-treated adult human endothelial cells proved their involvement in endothelial cell activation. Hence, we propose protein levels of kalirin and CHD7 in circulating EVs as novel endothelial dysfunction markers to monitor vascular condition in hypertensive patients with albuminuria.
Repisalud
Publication Artículo científico (JournalArticle)

Plasma Molecular Signatures in Hypertensive Patients With Renin-Angiotensin System Suppression: New Predictors of Renal Damage and De Novo Albuminuria Indicators

  • Baldan-Martin, Montserrat
  • Mourino-Alvarez, Laura
  • Gonzalez-Calero, Laura
  • Moreno-Luna, Rafael
  • Sastre-Oliva, Tamara
  • Ruiz-Hurtado, Gema
  • Segura, Julian
  • Lopez, Juan Antonio
  • Vazquez, Jesus
  • Vivanco, Fernando
  • Alvarez-Llamas, Gloria
  • Ruilope, Luis M
  • de la Cuesta, Fernando
  • Barderas, Maria G
Albuminuria is a risk factor strongly associated with cardiovascular disease, the first cause of death in the general population. It is well established that renin-angiotensin system suppressors prevent the development of new-onset albuminuria in naïf hypertensive patients and diminish its excretion, but we cannot forget the percentage of hypertensive patients who develop de novo albuminuria. Here, we applied multiple proteomic strategy with the purpose to elucidate specific molecular pathways involved in the pathogenesis and provide predictors and chronic organ damage indicators. Briefly, 1143 patients were followed up for a minimum period of 3 years. One hundred and twenty-nine hypertensive patients chronically renin-angiotensin system suppressed were recruited, classified in 3 different groups depending on their albuminuria levels (normoalbuminuria, de novo albuminuria, and sustained albuminuria), and investigated by multiple proteomic strategies. Our strategy allowed us to perform one of the deepest plasma proteomic analysis to date, which has shown 2 proteomic signatures: (1) with predictive value of de novo albuminuria and (2) sustained albuminuria indicator proteins. These proteins are involved in inflammation, immune as well as in the proteasome activation occurring in situations of endoplasmic reticulum stress. Furthermore, these results open the possibility of a future strategy based on anti-immune therapy to treat hypertension which could help to prevent the development of albuminuria and, hence, the progression of kidney damage.
Repisalud
Publication Artículo científico (JournalArticle)

Plasmid-Mediated Quinolone Resistance in Different Diarrheagenic Escherichia coli Pathotypes Responsible for Complicated, Noncomplicated, and Traveler's Diarrhea Cases

Repisalud
Publication Artículo científico (JournalArticle)

Mucus-Activatable Shiga Toxin Genotype stx2d in Escherichia coli O157:H7

  • Sánchez, Sergio
  • LLorente Rodríguez, Maria Teresa
  • Herrera-Leon, Laura
  • Ramiro-Jimenez, Raquel
  • Nebreda, Sandra
  • Remacha, María Antonia
  • Herrera-León, Silvia
We identified the mucus-activatable Shiga toxin genotype stx2d in the most common hemolytic uremic syndrome-associated Escherichia coli serotype, O157:H7. stx2d was detected in a strain isolated from a 2-year-old boy with bloody diarrhea in Spain, and whole-genome sequencing was used to confirm and fully characterize the strain.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Anthropometric Indicators as a Tool for Diagnosis of Obesity and Other Health Risk Factors: A Literature Review

  • Piqueras Fiszman, Paola
  • Ballester Fernandez, Alfredo
  • DURÁ-GIL, JUAN V.
  • Martinez-Hervas, Sergio
  • Redón, Josep
  • Real, José T.
[EN] Obesity is characterized by the accumulation of an excessive amount of fat mass (FM) in the adipose tissue, subcutaneous, or inside certain organs. The risk does not lie so much in the amount of fat accumulated as in its distribution. Abdominal obesity (central or visceral) is an important risk factor for cardiovascular diseases, diabetes, and cancer, having an important role in the so-called metabolic syndrome. Therefore, it is necessary to prevent, detect, and appropriately treat obesity. The diagnosis is based on anthropometric indices that have been associated with adiposity and its distribution. Indices themselves, or a combination of some of them, conform to a big picture with different values to establish risk. Anthropometric indices can be used for risk identification, intervention, or impact evaluation on nutritional status or health; therefore, they will be called anthropometric health indicators (AHIs). We have found 17 AHIs that can be obtained or estimated from 3D human shapes, being a noninvasive alternative compared to X-ray-based systems, and more accessible than high-cost equipment. A literature review has been conducted to analyze the following information for each indicator: definition; main calculation or obtaining methods used; health aspects associated with the indicator (among others, obesity, metabolic syndrome, or diabetes); criteria to classify the population by means of percentiles or cutoff points, and based on variables such as sex, age, ethnicity, or geographic area, and limitations., BODYPASS Project has received funding from the European Union's Horizon 2020 research and innovation program under Grant Agreement No. 779780. CIBER de Diabetes and Enfermedades Metabolicas Asociadas (CIBERDEM) is an Instituto de Salud Carlos III initiative. SM-H was an investigator in the Juan Rodes program (JR18/00051) financed by the Instituto de Salud Carlos III and the European Regional Development Fund (FEDER). Project (IMDEEA/2020/87) supported by Instituto Valenciano de Competitividad Empresarial (IVACE), call for proposals 2020 for Technology Centers of the Comunitat Valenciana, cofunded by ERDF Funds, EU Operational Program of the Comunitat Valenciana 2014-2020.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Is the long-term mortality similar in COVID-19 and community-acquired pneumonia?

  • Méndez, Raúl
  • González-Jiménez, Paula
  • Latorre, Ana
  • Mengot, Noé
  • Zalacain, Rafael
  • Ruiz, Luis A.
  • Serrano, Leyre
  • España, Pedro P.
  • Uranga, Ane
  • Cillóniz, Catia
  • Torres, Antoni
  • Menéndez, Rosario
  • Hervás-Marín, David|||0000-0003-0635-4961
[EN] There are no data on the association of type of pneumonia and long-term mortality by the type of pneumonia (COVID-19 or community-acquired pneumonia [CAP]) on long-term mortality after an adjustment for potential confounding variables. We aimed to assess the type of pneumonia and risk factors for long-term mortality in patients who were hospitalized in conventional ward and later discharged., This study received support by a non-conditional grant from Gebro Pharma Laboratories, which did not participate in the design, data collection, statistical analysis or writing of the article. El Instituto de Salud Carlos III (ISCIII) through Project [PI17/01421] and Project [COV20/00385] (co-funded by the European Regional Development Fund/European Social Fund. Investing in your future ). Sociedad Española de Neumología y Cirugía Torácica (SEPAR): 1078/2020. Sociedad Española de Neumología y Cirugía Torácica (SEPAR): Convocatoria extraordinaria PII Infecciones Respiratorias 2011. RaM is the recipient of a Juan Rodés grant, supported by the Instituto de Salud Carlos III (ISCIII [JR21/00051]). PG-J is the recipient of a postresident research grant supported by the Health Research Institute La Fe (2019-053-1). CC received a grant from the Fondo de Investigación Sanitaria (PI19/00207), Instituto de Salud Carlos III, co-funded by the European Union.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

The Long-term Pneumonia Mortality Index: an international multicenter derivation and validation study for patients with community-acquired pneumonia

  • Mendez, Raul
  • Gonzalez-Jimenez, Paula
  • Latorre, Ana
  • Piqueras, Monica
  • Mengot, Noe
  • Knox, Daniel
  • Carr, Jason
  • Barten-Neiner, Grit
  • Rohde, Gernot
  • Pletz, Mathias W.
  • Rupp, Jan
  • Witzenrath, Martin
  • Dean, Nathan C.
  • Menendez, Rosario
  • Hervás-Marín, David|||0000-0003-0635-4961
[EN] Rationale: Long-term mortality after hospital discharge in community-acquired pneumonia (CAP) is a neglected issue. A validated, accurate score predicting mortality is needed. Objective: To derive and validate the Long-term Pneumonia Mortality Index (L-PMI). Methods: L-PMI derivation used data from a Spanish multicenter prospective study on CAP with a 1-year follow-up. A logistic regression model for predicting 1-year mortality risk was developed. Performance of the model was assessed by estimating the area under the receiver operating characteristic curve (AUC). The model was externally validated using 2 independent multicenter CAP cohorts from Germany and the United States (USA), and one COVID-19 pneumonia cohort from Spain. We then derived a score from the model to ease its application. Measurements and main results: The long-term mortality rate after discharge was 6.3%, 4.4%, 17.4%, and 3.6% in the derivation, CAPNETZ (only 6 months of follow-up), USA, and COVID-19 cohorts, respectively. The L-PMI included age, smoking history, nursing home residency, Charlson Comorbidity Index score, CURB-65 score, use of noninvasive or invasive mechanical ventilation, and in-hospital cardiovascular events. The L-PMI showed high discrimination for mortality in the derivation cohort (AUC, 0.82 [95% CI, 0.78-0.85]). In the validation cohorts, the AUC (95% CI) ranged from 0.78 (0.73-0.83) to 0.75 (0.73-0.77) for the CAPNETZ and USA cohorts, respectively, and 0.88 (0.84-0.93) for the COVID-19 cohort. L-PMI allows classification of patients according to their mortality risk into low-, intermediate-, and high-risk groups. Conclusions: The L-PMI is a novel clinical prediction score that identifies pneumonia patients at risk of mortality up to 1 year after discharge., This study was supported by: Instituto de Salud Carlos III (ISCIII) through Project PI22/01712 (co-funded by the European Union) R. Mendez is the recipient of a Juan Rodes grant, supported by the ISCIII (JR21/00051) (co-funded by the European Union). P.G.-J. is the recipient of a Rio Hortega grant, supported by the ISCIII (CM23/00062) (co-funded by the European Union). M.P. is the recipient of a postresident research grant supported by the Health Research Institute La Fe (2023-875-1). J.C. and N.C.D. are supported by the Agency for Healthcare Research and Quality through project R18 HS28955-02.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Lung Cancer and SARS-CoV-2 infection: Identifying important knowledge gaps for investigation

  • Rolfo, Christian
  • Meshulami, Noy
  • Russo, Alessandro
  • Krammer, Florian
  • Garcia-Sastre, Adolfo
  • Mack, Philip C.
  • Gomez, Jorge E.
  • Bhardwaj, Nina
  • Benyounes, Amin
  • Moore, Amy
  • Rohs, Nicholas
  • Henschke, Claudia I.
  • Yankelevitz, David
  • King, Jennifer
  • Sirera Pérez, Rafael|||0000-0001-9162-8490
[EN] Patients with lung cancer are especially vulnerable to coronavirus disease 2019 (COVID-19) with a greater than sevenfold higher rate of becoming infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) COVID-19, a greater than threefold higher hospitalization rate with high complication rates, and an estimated case fatality rate of more than 30%. The reasons for the increased vulnerability are not known. In addition, beyond the direct impact of the pandemic on morbidity and mortality among patients with lung cancer, COVID-19, with its disruption of patient care, has also resulted in substantial impact on lung cancer screening and treatment/management.COVID-19 vaccines are safe and effective in people with lung cancer. On the basis of the available data, patients with lung cancer should continue their course of cancer treatment and get vaccinated against the SARS-CoV-2 virus. For unknown reasons, some patients with lung cancer mount poor antibody responses to vaccination. Thus, boosting vaccination seems urgently indicated in this subgroup of vulnerable patients with lung cancer. Nevertheless, many unanswered questions regarding vaccination in this population remain, including the magnitude, quality, and duration of antibody response and the role of innate and acquired cellular immunities for clinical protection. Additional important knowledge gaps also remain, including the following: how can we best protect patients with lung cancer from developing COVID-19, including managing care in patient with lung cancer and the home environment of patients with lung cancer; are there clinical/treatment demographics and tumor molecular demographics that affect severity of COVID-19 disease in patients with lung cancer; does anticancer treatment affect antibody production and protection; does SARS-CoV-2 infection affect the develop-ment/progression of lung cancer; and are special measures and vaccine strategies needed for patients with lung cancer as viral variants of concern emerge., Work in the Krammer laboratory on severe acute respiratory syndrome coronavirus 2. is supported by the National Institute of Allergy and Infectious Dis-eases Collaborative Influenza Vaccine Innovation Cen-ters contract 75N93019C00051, the Centers of Excellence for Influenza Research and Surveillance (contract #HHSN272201400008C) , the JPB Foundation, the Open Philanthropy Project (research grant 2020-215611 [5384]) , and anonymous donors. In addition, serology efforts in the Krammer laboratory are sup-ported by the National Cancer Institute SeroNet grant U54CA260560 and by the SeroNet in part with federal funds from the National Cancer Institute, National Institutes of Health, under contract number 75N91019D00024, task order number 75N91021F00001. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government.
Repositori Institucional UIB
Publication Artículo científico (JournalArticle)

The influence of grafting on crops' photosynthetic performance

  • Fullana-Pericàs, Mateu
  • Conesa, Miquel À.
  • Pérez-Alfocea, Francisco
  • Galmés, Jeroni
[eng] In a near scenario of climate change where stress-derived limitations on crop yield by affecting plant gas-exchange are expected, grafting may become a cheap and easy technique to improve crops photosynthetic performance and water-use efficiency. Inconsistent data of the effect of rootstocks over gas-exchange can be found in literature, being necessary an integrative analysis of the effect of grafting over photosynthetic parameters. With this aim, we present a compilation of the effect of graft on the net CO2 assimilation rate (AN) and other photosynthetic parameters across different species with agronomic interest. No differences were observed in any photosynthetic parameter between non-grafted and self-grafted plants under non-stress conditions. However, differences were found depending on the used rootstock, particularly for the intrinsic water-use efficiency (WUE). We observed that variations in AN induced by rootstocks were related to changes in both diffusive and biochemical parameters. Under drought or salt stress, different photosynthetic performance was observed depending on the rootstock, although the high variability among studies leaded to remarkable results. Overall, we observed that grafting can be a useful technique to improve plant photosynthetic performance, and therefore, crop yield and WUE, and that the rootstock selection for a target environment is determinant for the variations in photosynthesis.
Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
Publication Artículo científico (JournalArticle)

Antiseptics as effective virucidal agents against SARS-CoV-2: Systematic review and Bayesian network meta-analysis

  • Seijas Otero, Noelia
  • Blanco Pintos, Triana
  • Regueira Iglesias, Alba
  • Suárez Rodríguez, Berta
  • Sánchez Barco, Alba
  • Balsa Castro, Carlos
  • Tomás Carmona, Inmaculada
This study represents the first Bayesian network meta-analysis (NMA), which aimed to determine the virucidal efficacy of oral and nasal antiseptics against SARS-CoV-2 in saliva. Eligible studies evaluated the antiseptics’ effect on viral load in SARS-CoV-2-infected subjects. The search was performed in September 2024 through PubMed, World Health Organisation, Embase, Scopus, bioRxiv, and medRxiv. The methodological quality was evaluated using the Cochrane RoB-2 checklist. Twenty-six articles and 16 antiseptics were assessed. Bayesian NMA was possible for seven antiseptics, ranked by probability of best option for viral load reduction (SUCRA values): PVP-I (0.85); CPC and CHX (0.72); H 2 O 2 (0.70); CHX (0.64); CPC (0.50); H and CHX (0.38); and HClO (0.34). Virucidal efficacy at baseline was significant for (viral load reduction): PVP-I (42 %), H 2 O 2 and CHX (31 %). Compared to the control group, PVP-I remained significant (34 %), whereas H 2 2 O O 2 2 (34 %), and CHX approached significance (26 % and 22 %, respectively). In conclusion, a single application of PVP-I, H or CHX are the best options for reducing the SARS-CoV-2 viral load in saliva, which can be particularly relevant in high- risk settings. However, methodologically well-designed studies using more appropriate quantification techniques are needed to clarify better the clinical efficacy of antiseptics against SARS-CoV-2 and other respiratory viruses.
eBiltegia. Repositorio Institucional de Mondragon Unibertsitatea
Publication Contribución de congreso (ConferenceOutput)

Simulation based IEEE 802.11ad performance assessment in factory workshop

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Complementary contribution of wild bumblebees and managed honeybee to the pollination niche of an introduced blueberry crop

  • Miñarro, Marcos
  • García, Daniel
The entomophilous pollination niche (abundance, phenotypic traits, foraging behaviours and environmental tolerances of insect pollinators) helps to understand and better manage crop polli-nation. We apply this niche approach to assess how an entomophilous crop (blueberry, Vaccinium ashei) can be expanded into new territories (i.e., northern Spain) far from their original area of domestication (North America). Insect visits to blueberry flowers were monitored in a plantation on 12 different days, at 8 different times during day and covering various weather conditions. Abundance, visitation rate, pollen gathering behaviour, and frequency of inter-plant and inter-row movements were recorded. The pollinator assemblage was basically composed of one managed honeybee species (50.8% of visits) and three native bumblebee species (48.3%). There was a marked pattern of seasonal segregation throughout bloom, with bumblebees dominating the early bloom and honeybee the late bloom. Pollinators also segregated along gradients of daily temperature and relative humidity. Finally, the two pollinator types differed in foraging behaviour, with bumblebees having a visitation rate double that of honeybee, collecting pollen more frequently and changing plant and row more frequently. The spatio-temporal and functional complementarity between honeybee and bumblebees suggested here encourages the consideration of an integrated crop pollination strategy for blueberries, based on the concurrence of both wild and managed bees., The study was supported by grants INIA-RTA2013-00139-C03-01 and INIA-RTA2017-00051-C02-01 (Ministerio de Economía, Industria y Competitividad (MinECo) and Fondo Europeo de Desarrollo Regional) to MM.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Do farmers care about pollinators? A cross-site comparison of farmers’ perceptions, knowledge, and management practices for pollinator-dependent crops

  • Hevia, Violeta
  • García-Llorente, Marina
  • Martínez-Sastre, Rodrigo
  • Palomo, Sara
  • García, Daniel
  • Miñarro, Marcos
  • Pérez-Marcos, María
  • Sánchez, Juan Antonio
  • González, José A.
Pollinator conservation has become a key challenge to achieve sustainable agricultural landscapes and safeguard food supplies. Considering the potential negative effects of pollinator decline, international efforts have been developed to promote agri-environmental measures and pollinator-friendly management practices. However, little effort has been devoted to farmers’ perceptions and knowledge about pollinators, or to farmers’ role in enhancing pollination. We administered 376 face-to-face questionnaires in four areas of Spain with different dominant pollinator-dependent crops, to assess the factors behind farmers’ perceptions, knowledge, and practices adopted to promote pollination. Overall, 92.7% of the respondents recognized that pollinator insects are necessary for crop production, and 73.4% perceived pollinator decline in their farms. We found that farmers had moderate knowledge about pollinators (6.1 ± 1.8, on a 1–10 scale). The most applied practices to promote pollinators were reducing insecticide spraying (53.2% of respondents), diversifying crops (42.8%), and increasing fallow fields (39.1%). Factors such as education, age, concern about the pollinator crisis, and professional dedication to agriculture strongly influenced farmers’ knowledge and current application of pollinator-friendly practices. Implications of our results for the ongoing reform of the Common Agricultural Policy are discussed, highlighting the need to increase engagement and trust of farmers through communication and technical assistance., This work was supported by the European Union FEDER INTERREG SUDOE program (Project POLL-OLE-GI, SOE1/P5/E0129), MINECO and FEDER (INIA-RTA2017-00051-C02-00 to MM and JAS), and a FPI-INIA CPD2015-0059 fellowship to RMS. This study also received funding from: (1) the Simbiosis Api- project Agro funded by the European Union, the Spanish Ministry of Agriculture, Food and the Environment and the Madrid Regional Government under the Rural Development Programme (RDP-CM 2014-2020) (2) the European Union’s Horizon 2020 research and innovation program under grant agreement N 81819, and (3) the R&D projects for young researchers at the Autonomous University of Madrid by providing funds for this research through SAVIA project (ref SI1/PJI/2019-00444).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Top-down and bottom-up regulation of codling moth populations in cider apple orchards

  • Martínez-Sastre, Rodrigo
  • Peña García, Rocío
  • González-Ibáñez, Alejandro
  • García, Daniel
  • Miñarro, Marcos
The success of biological control by natural enemies in agricultural crops relies on an understanding of the trophic interactions between natural enemies, pests and host plants. Top-down and bottom-up trophic effects, together with potential landscape and local-scale factors, may regulate pest populations. For two years, we analyzed codling moth populations (Cydia pomonella), their crop damage and their parasitoid communities in 26 low-input cider apple orchards in northern Spain. Codling moth abundance was estimated from overwintering larvae sampled with cardboard traps on trees, parasitism was estimated from parasitoids emerged from lab-reared moth larvae, and pest damage was assessed in apples before ripening. Codling moth abundance differed between orchards across years, and was positively correlated with apple production and the cover of apple plantations in the surrounding landscape. The effects of the apple production on codling moth abundance suggest bottom-up pest regulation. Apple damage in individual orchards reached 71%, but decreased with apple production, indicating codling moth satiation. Seven parasitoid species were recorded on codling moth larvae. Parasitism rate in individual orchards reached 42.5% of codling moth larvae. The number of parasitized larvae per orchard was positively related to parasitoid richness, but also to codling moth abundance, suggesting simultaneous top-down and bottom-up effects between parasitoids and pest. This study highlights the need to tackle the whole parasitoid-pest-plant system in order to better manage codling moth damage in orchards. The conservation of complementary parasitoid species through biodiversity-friendly actions should be combined with the control of apple production at the orchard- and landscape scale., Funding was provided by FPI fellowships to RMS (INIA, CPD2015-0059) and RP (BES-2016-078260), and through grants INIA-RTA2013-00139-C03-01 and RTA2017-00051-C02-01 (Ministerio de Economía, Industria y Competitividad (MinECo)) and Fondo Europeo de Desarrollo Regional to MM, PCIN2014-145-C02-02 (MinECo; EcoFruit project BiodivERsA-FACCE2014-74) and CGL2015-68963-C2-2-R (MinECo) to DG. Funding sources had no involvement in study design, collection, analysis or interpretation of data, the writing of the report or the decision to submit the article for publication.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Assessing cellulose nanofiber production from olive tree pruning residue

  • Fillat, Ursula
  • Martín-Sampedro, Raquel
  • Ibarra, David
  • Ruiz-Hitzky, Eduardo
  • Valencia, Concepción
  • Sarrión, A.
  • Castro, Elena
  • Eugenio, María E.
  • Wicklein, Bernd
Pruning operation in olive trees generates a large amount of biomass that is normally burned causing severe environmental concern. Therefore, the transformation of this agricultural residue into value-added products is imperative but still remains as a technological challenge. In this study, olive tree pruning (OTP) residue is evaluated for the first time to produce cellulose nanofibers (CNF). The OTP bleached pulp was treated by TEMPO-mediated oxidation and subsequent defibrillation in a microfluidizer. The resulting CNF was characterized and compared to CNF obtained from a commercial bleached eucalyptus kraft pulp using the same chemi-mechanical procedure. CNF from OTP showed higher carboxylate content but lower fibrillation yield and optical transmittance as compared to eucalyptus CNF. Finally, the visco-elastic gel obtained from OTP was stronger than that produced from eucalyptus. Therefore, the properties of CNF from OTP made this nanomaterial suitable for several applications. CNF from OTP showed higher carboxylate content as compared to eucalyptus CNF (1038 vs. 778 μmol/g) but lower fibrillation yield (48% vs. 96%) and optical transmittance. Finally, the visco-elastic gel obtained from OTP was stronger than that produced from eucalyptus. Therefore, the properties of CNF from OTP made this nanomaterial suitable for several applications., This work was supported by the Spanish Ministry of Economy and Competitiveness (MINECO) via Projects CTQ2013-47158-R, RTA2015-00051-00-00, MAT2015-71117-R and Programme PTA2014-09248-I. BW acknowledges an IJCI contract., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Characterization of lignins from Populus alba L. generated as by-products in different transformation processes Kraft pulping, organosolv and acid hydrolysis

  • Martín-Sampedro, Raquel
  • Santos, José I.
  • Fillat, Ursula
  • Eugenio, María E.
  • Ibarra, David
  • Wicklein, Bernd
The complexity and heterogeneity of lignin requires a detailed understanding in order to decide about more efficient lignin valorization approaches. This study deals with the characterization of lignins from Populus alba L. generated as by-products in different transformation processes: kraft pulping, organosolv and dilute acid hydrolysis. In addition to the composition, the chemical and structural features of the different lignins were investigated by Fourier Transform infrared spectroscopy (FTIR), solid-state 13C nuclear magnetic resonance (13C NMR), two-dimensional nuclear magnetic spectrometry (2D NMR), size exclusion chromatography (SEC), and thermal analysis. Organosolv lignin showed noticeably different characteristics compared to kraft and acid hydrolysis lignins; higher molar mass, higher amount of side-chain linkages (mainly aryl-β ether and resinol) together with lower phenolic content. On the contrary, kraft and acid hydrolysis lignins presented an extensive elimination of lateral chains and therefore a higher phenolic content, which suggests a much stronger lignin depolymerization (lower molar mass) during these processes. Moreover, thermal analysis results revealed that the thermal stability of kraft and acid hydrolysis lignins was higher than that of organosolv lignin, especially in the case of acid hydrolysis lignin. According to all these characteristics, several valorization pathways for studied lignin are discussed., The authors wish to thank the MINECO for funding this study via Project MAT2015-71117-R, CTQ2013-47158-R and RTA2015-00051-00-00. BW acknowledges an IJCI contract., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

The relationship between genetic liability, childhood maltreatment, and IQ: findings from the EU-GEI multicentric case–control study

  • Sideli, Lucia
  • Aas, Monica
  • Quattrone, Diego
  • La Barbera, Daniele
  • La Cascia, Caterina
  • Ferraro, Laura
  • Alameda, Luis
  • Velthorst, Eva
  • Trotta, Giulia
  • Tripoli, Giada
  • Schimmenti, Adriano
  • Fontana, Andrea
  • Gayer-Anderson, Charlotte
  • Stilo, Simona
  • Seminerio, Fabio
  • Sartorio, Crocettarachele
  • Marrazzo, Giovanna
  • Lasalvia, Antonio
  • Tosato, Sarah
  • Tarricone, Ilaria
  • Berardi, Domenico
  • D’Andrea, Giuseppe
  • EU-GEI WP2 Group
  • Arango, Celso
  • Arrojo, Manuel
  • Bernardo, Miguel
  • Bobes, Julio
  • Sanjuán, Julio
  • Santos, José Luis
  • Rossi Menezes, Paulo
  • Del-Ben, Cristina Marta
  • Jongsma, Hannah E.
  • Jones, Peter B.
  • Kirkbride, James B.
  • Llorca, Pierre-Michel
  • Tortelli, Andrea
  • Pignon, Baptiste
  • Haan, Lieuwe de
  • Selten, Jean-Paul
  • Os, Jim van
  • Rutten, Bart P. F.
  • Bentall, Richard
  • Di Forti, Marta
  • Murray, Robin M.
  • Morgan, Craig
  • Fisher, Helen L.
© The Author(s) 2023. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/., This study investigated if the association between childhood maltreatment and cognition among psychosis patients and community controls was partially accounted for by genetic liability for psychosis. Patients with first-episode psychosis (N = 755) and unaffected controls (N = 1219) from the EU-GEI study were assessed for childhood maltreatment, intelligence quotient (IQ), family history of psychosis (FH), and polygenic risk score for schizophrenia (SZ-PRS). Controlling for FH and SZ-PRS did not attenuate the association between childhood maltreatment and IQ in cases or controls. Findings suggest that these expressions of genetic liability cannot account for the lower levels of cognition found among adults maltreated in childhood., We are grateful to the EU-GEI study participants for their essential contribution to this project. The EU-GEI Study is funded by grant agreement HEALTH-F2-2010–241909 (Project EU-GEI) from the European Community’s Seventh Framework Programme, and Grant 2012/0417–0 from the São Paulo Research Foundation. B.P.F. Rutten is funded by a VIDI award (no. 91.718.336) from the Netherlands Scientific Organization. H. L. Fisher, C. Gayer-Anderson, and C. Morgan are supported by the Economic and Social Research Council (ESRC) Centre for Society and Mental Health at King’s College London [ES/S012567/1]. D. Quattrone is supported by the Medical Research Council Clinical Academic Research Partnership [MR/W030608/1]. M. Aas is supported by an MRC fellowship (#MR/WO27720/1). C. Arango has received support from the Spanish Ministry of Science and Innovation, Instituto de Salud Carlos III (ISCIII), co-financed by the European Union, ERDF Funds from the European Commission, “A way of making Europe”, financed by the European Union—NextGenerationEU (PMP21/00051, PI19/01024), CIBERSAM, Madrid Regional Government (B2017/BMD-3740 AGES-CM-2), European Union Structural Funds, European Union Seventh Framework Program, European Union H2020 Program under the Innovative Medicines Initiative 2 Joint Undertaking: Project PRISM-2 (Grant agreement No.101034377), Project AIMS-2-TRIALS (Grant agreement No 777394), Horizon Europe, the National Institute of Mental Health of the National Institutes of Health under Award Number 1U01MH124639-01 (Project ProNET) and Award Number 5P50MH115846-03 (Project FEP-CAUSAL), Fundación Familia Alonso, and Fundación Alicia Koplowitz. The views expressed are those of the authors and not necessarily those of the ESRC or King’s College London., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Pollination of exotic fruit crops depends more on extant pollinators and landscape structure than on local management of domestic bees

  • Miñarro, Marcos
  • García, Daniel
  • Rosa-García, Rocío
Agricultural globalization has driven the expansion of exotic crops into new agricultural areas. Pollinator-dependent exotic crops not only have to face the abiotic constraints of the new cultivation regions but also deal with local pollinator assemblages, which may or may not fulfill pollination requirements. Here, we studied how three entomophilous exotic crops (kiwifruit, northern highbush blueberry and rabbiteye blueberry) adapt to a common pollination environment in new cultivation areas in Spain. For this, we assessed the pollination limitation of those crops, the contribution of insect assemblages to the pollination service, and the effect of landscape structure and the management of domestic pollinators on these assemblages. The three exotic crops showed large and diverse pollinator assemblages but differed in the assemblage composition and in the identity of the main pollinator species. Honeybee clearly dominated kiwifruit assemblages, representing almost 70 % of visits to flowers. Bumblebees and honeybee fairly equally dominated floral visits in highbush blueberry, and bumblebees accounted for more than 90% of visits in rabbiteye blueberry. Floral morphology partially explained interspecific differences in pollinator assemblages and led to the distinct contributions of the different insects to the different crops. Kiwifruit (but not blueberry) crops experienced pollination limitation that led to, on average, a 7.2 % reduction in fruit weight. This pollination limitation decreased when honeybee abundance rose. In all three crops, the local pollinator assemblages mostly depended on the landscape structure around orchards but were only affected by the management of domestic pollinators in rabbiteye blueberry crops. Our results highlight the importance of understanding the interspecific differences in the pollination ecology of new exotic crops before designing general management recommendations, and also question the use of managed pollinators before making an assessment of the contribution of extant insects to the pollination service., This work was supported by MinECo/MCIN/AEI/10.13039/501100011033/FEDER Grants E-RTA2013-00072-C03, RTA2017-00051-C02-01, GRUPIN IDI/2018/000151 y PID2020-120239RR-100., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Exploring the Impact of Schizophrenia and Its Pharmacological Treatment on Health-Related Quality of Life and Treatment Preferences

  • Arango, Celso
  • Baeza, Inmaculada
  • García-Rizo, Clemente
  • Crespo-Facorro, Benedicto
  • Lahera, Guillermo
  • Vieta, Eduard
  • Becker, Frauke
  • Dwyer, Georges
  • Bourke, Siobhan
  • Gibson, Adam
  • Gabarda-Inat, Irene
  • Álvarez-Baron, Elena
The abstract of this paper was presented at the 36th ECNP Congress 2023 (Barcelona 7-10 October) as a poster presentation with interim findings. The poster’s abstract was published in Abstracts of the 36th ECNP Congress 2023 in Neuroscience applied (Vol2, Supplement 2): https://doi.org/10.1016/j.nsa.2023.103062., [Purpose:] Pharmacological treatments play an important role in managing symptoms of schizophrenia but can also be associated with side effects. The aim of this study was to understand the impact of schizophrenia and its pharmacological treatment on patients’ health-related quality of life (HRQoL) and to explore patient preferences around treatment benefits and side effects., [Patients and Methods:] This study employed a mixed methods approach with two stages of recruitment of adult patients in Spain. Stage 1 included qualitative and quantitative elements (including included two validated patient-reported outcome measures: PETiT and EQ-5D-5L) administered in telephone interviews with people with schizophrenia. Stage 2 consisted of a quantitative online survey completed by people with schizophrenia attending outpatient clinics. Responses to quantitative items across both stages were combined for analysis., [Results:] Twenty respondents completed the mixed methods interviews (stage 1), and 25 participants completed the online survey (stage 2). Results from stages 1 and 2, showed that participants perceived treatments to have a beneficial impact on controlling their symptoms. However, cognitive side effects were reported to have a detrimental impact on respondents’ daily life and were considered a primary reason for treatment cessation in the past. Qualitative findings further showed that most participants hoped future treatments would minimise the impact of cognitive symptoms of schizophrenia., [Conclusion:] The findings suggest that patients’ expectation around treatment efficacy and their acceptability of treatment side effects may indicate their capacity to maintain long-term treatment adherence. Trade-offs that patients may be willing to make between these components may prove useful to consider in clinical practice to improve treatment adherence and hence treatment effectiveness in people with schizophrenia., CA has been supported by the Spanish Ministry of Science and Innovation, Instituto de Salud Carlos III (ISCIII), co-financed by the European Union, ERDF Funds from the European Commission, “A way of making Europe”, financed by the European Union - NextGenerationEU (PMP21/00051), PI19/01024, PI22-01824.CIBERSAM, Madrid Regional Government (B2017/BMD-3740 AGES-CM-2), European Union Structural Funds, European Union Seventh Framework Program, European Union H2020 Program under the Innovative Medicines Initiative 2 Joint Undertaking: Project PRISM-2 (Grant agreement No.101034377), Project AIMS-2-TRIALS (Grant agreement No 777394), Horizon Europe, the National Institute of Mental Health of the National Institutes of Health under Award Number 1U01MH124639-01 (Project ProNET) and Award Number 5P50MH115846-03 (project FEP-CAUSAL), Fundación Familia Alonso, and Fundación Alicia Koplowitz. IB has been supported by the Spanish Ministry of Science and Innovation, Instituto de Salud Carlos III (PI21/0391), co-financed by the European Union, Drugs National Plan (2022I053) and Fundación Alicia Koplowitz., Peer reviewed
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Progressive Telomere Dysfunction Causes Cytokinesis Failure and Leads to the Accumulation of Polyploid Cells

  • Pampalona Sala, Judit|||0000-0001-9454-0734
  • Frías García, Cristina
  • Tusell Padrós, Laura|||0000-0002-2848-345X
  • Genescà, Anna|||0000-0002-0509-956X
Most cancer cells accumulate genomic abnormalities at a remarkably rapid rate, as they are unable to maintain their chromosome structure and number. Excessively short telomeres, a known source of chromosome instability, are observed in early human-cancer lesions. Besides telomere dysfunction, it has been suggested that a transient phase of polyploidization, in most cases tetraploidization, has a causative role in cancer. Proliferation of tetraploids can gradually generate subtetraploid lineages of unstable cells that might fire the carcinogenic process by promoting further aneuploidy and genomic instability. Given the significance of telomere dysfunction and tetraploidy in the early stages of carcinogenesis, we investigated whether there is a connection between these two important promoters of chromosomal instability. We report that human mammary epithelial cells exhibiting progressive telomere dysfunction, in a pRb deficient and wild-type p53 background, fail to complete the cytoplasmatic cell division due to the persistence of chromatin bridges in the midzone. Flow cytometry together with fluorescence in situ hybridization demonstrated an accumulation of binucleated polyploid cells upon serial passaging cells. Restoration of telomere function through hTERT transduction, which lessens the formation of anaphase bridges by recapping the chromosome ends, rescued the polyploid phenotype. Live-cell imaging revealed that these polyploid cells emerged after abortive cytokinesis due to the persistence of anaphase bridges with large intervening chromatin in the cleavage plane. In agreement with a primary role of anaphase bridge intermediates in the polyploidization process, treatment of HMEC-hTERT cells with bleomycin, which produces chromatin bridges through illegimitate repair, resulted in tetraploid binucleated cells. Taken together, we demonstrate that human epithelial cells exhibiting physiological telomere dysfunction engender tetraploid cells through interference of anaphase bridges with the completion of cytokinesis. These observations shed light on the mechanisms operating during the initial stages of human carcinogenesis, as they provide a link between progressive telomere dysfunction and tetraploidy. Chromosome instability leads to the accumulation of chromosome number and structure aberrations that have been suggested as necessary for neoplastic transformation. Telomeres, specialized DNA-protein complexes localized at the physical ends of linear chromosomes, are crucial for maintaining chromosome stability. Massive chromosomal instability may occur when cells continuously proliferate in the absence of specific telomere elongation mechanisms. Besides telomere dysfunction, it has been suggested that a transient phase of tetraploidization has a causative role in cancer. This study provides a link between dysfunctional telomeres and the generation of tetraploids. Using a human mammary epithelial cell model, we show that diploid cells exhibiting progressive telomere dysfunction, in a p53 proficient background, engender tetraploid cells through cytokinesis failure. Our studies give new insights into the mechanisms that may facilitate the evolution of malignant phenotypes: telomere-dependent chromosome instability would engender tetraploid intermediates that, on division, would promote further cellular genome remodelling, which is needed at the early stages of tumour development in order for cells to become neoplasic.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Prevalence of cardiovascular risk factors in people with epilepsy

  • Vivanco-Hidalgo, Rosa Maria|||0000-0001-7547-0291
  • Gómez González, Alejandra
  • Moreira Villanueva, Antía|||0000-0002-6395-5184
  • Díez, Laura
  • Elosua, Roberto|||0000-0001-8235-0095
  • Roquer González, Jaume|||0000-0001-5992-2606
Epilepsy has been associated with cardiovascular comorbidity. This study aimed to assess the potential association between cardiovascular risk factors (s), antiepileptic drugs (s), and etiology. A single-center retrospective epilepsy cohort from the decade of 2004-2013 was assessed. Poisson regression models with robust variance were estimated to obtain prevalence ratios () according to prescription and etiology. After excluding patients in the monotherapy group with vascular etiology or previous cardiovascular events, in the remaining 400 patients, enzyme-inducer s (s), especially phenytoin (), were associated with higher prevalence of dyslipidemia (a 1.77, p < .05), compared to valproic acid. No etiology was associated with higher prevalence of any . Patients treated with s, especially , had higher prevalence of dyslipidemia.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Targeting antitumoral proteins to breast cancer by local administration of functional inclusion bodies

  • Pesarrodona Roches, Mireia|||0000-0001-9669-8471
  • Jauset González, Toni|||0000-0003-2869-5804
  • Díaz Riascos, Zamira Vanessa|||0000-0003-1595-618X
  • Sánchez Chardi, Alejandro|||0000-0002-8789-1883
  • Beaulieu, Marie-Eve|||0000-0001-5224-8436
  • Seras-Franzoso, Joaquin|||0000-0002-7893-4773
  • Sánchez-García, Laura|||0000-0002-8420-1701
  • Baltà Foix, Ricardo
  • Mancilla, Sandra|||0000-0002-9681-3588
  • Fernández Caparrós, Yolanda
  • Rinas, Ursula
  • Schwartz, Simon|||0000-0001-8297-7971
  • Soucek, Laura|||0000-0002-4750-7971
  • Villaverde, Antonio|||0000-0002-2615-4521
  • Abasolo, Ibane|||0000-0001-5970-6276
  • Vázquez, Esther|||0000-0003-1052-0424
Two structurally and functionally unrelated proteins, namely Omomyc and p31, are engineered as CD44-targeted inclusion bodies produced in recombinant bacteria. In this unusual particulate form, both types of protein materials selectively penetrate and kill CD44 tumor cells in culture, and upon local administration, promote destruction of tumoral tissue in orthotropic mouse models of human breast cancer. These findings support the concept of bacterial inclusion bodies as versatile protein materials suitable for application in chronic diseases that, like cancer, can benefit from a local slow release of therapeutic proteins.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Selective delivery of T22-PE24-H6 to CXCR4 + diffuse large B-cell lymphoma cells leads to wide therapeutic index in a disseminated mouse model

  • Falgàs, Aïda|||0000-0002-5040-2265
  • Pallarès, Victor|||0000-0002-9851-0345
  • Serna, Naroa|||0000-0001-5682-8198
  • Sánchez-García, Laura|||0000-0002-8420-1701
  • Sierra, Jorge|||0000-0002-7966-0356
  • Gallardo, Alberto|||0000-0002-2514-2027
  • Alba Castellón, Lorena|||0000-0003-3449-7820
  • Álamo, Patricia|||0000-0003-0510-5701
  • Unzueta Elorza, Ugutz|||0000-0001-5119-2266
  • Villaverde, Antonio|||0000-0002-2615-4521
  • Vázquez, Esther|||0000-0003-1052-0424
  • Mangues, Ramon|||0000-0003-2661-9525
  • Casanova Rigat, Isolda|||0000-0002-1196-4724
Background : Novel therapeutic strategies are urgently needed to reduce relapse rates and enhance survival in Diffuse Large B-Cell Lymphoma (DLBCL) patients. CXCR4-overexpressing cancer cells are good targets for therapy because of their association with dissemination and relapse in R-CHOP treated DLBCL patients. Immunotoxins that incorporate bacterial toxins are potentially effective in treating haematological neoplasias, but show a narrow therapeutic index due to the induction of severe side effects. Therefore, when considering the delivery of these toxins as cancer therapeutics, there is a need not only to increase their uptake in the target cancer cells, and their stability in blood, but also to reduce their systemic toxicity. We have developed a therapeutic nanostructured protein T22-PE24-H6 that incorporates exotoxin A from Pseudomonas aeruginosa, which selectively targets lymphoma cells because of its specific interaction with a highly overexpressed CXCR4 receptor (CXCR4 +) in DLBCL. Methods : T22-PE24-H6 cytotoxicity and its dependence on the CXCR4 receptor were evaluated in DLBCL cell lines using cell viability assays. Different in vitro experiments (mitochondrial membrane potential, Western Blot, Annexin V and DAPI staining) were conducted to determine T22-PE24-H6 cell death mechanisms. In vivo imaging and therapeutic effect studies were performed in a disseminated DLBCL mouse model that mimics organ infiltration in DLBCL patients. Finally, immunohistochemistry and histopathology analyses were used to evaluate the antineoplastic effect and systemic toxicity. Results : In vitro, T22-PE24-H6 induced selective cell death of CXCR4 + DLBCL cells by activating the apoptotic pathway. In addition, repeated T22-PE24-H6 intravenous administration in a CXCR4 + DLBCL-disseminated mouse model showed a significant reduction of lymphoma burden in organs clinically affected by DLBCL cells (lymph nodes and bone marrow). Finally, we did not observe systemic toxicity associated to the nanoparticle treatment in non-DLBCL-infiltrated organs. Conclusion : We have demonstrated here a potent T22-PE24-H6 antineoplastic effect, especially in blocking dissemination in a CXCR4 + DLBCL model without associated toxicity. Thereby, T22-PE24-H6 promises to become an effective alternative to treat CXCR4 + disseminated refractory or relapsed DLBCL patients.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Nanostructure empowers active tumor targeting in ligand-based molecular delivery

  • López-Laguna, Hèctor|||0000-0001-5249-8304
  • Sala, Rita
  • Sánchez, Julieta M.|||0000-0001-6676-5776
  • Álamo, Patricia|||0000-0003-0510-5701
  • Unzueta Elorza, Ugutz|||0000-0001-5119-2266
  • Sánchez Chardi, Alejandro|||0000-0002-8789-1883
  • Serna, Naroa|||0000-0001-5682-8198
  • Sánchez-García, Laura|||0000-0002-8420-1701
  • Voltà-Durán, Eric|||0000-0003-0017-8274
  • Mangues, Ramon|||0000-0003-2661-9525
  • Villaverde, Antonio|||0000-0002-2615-4521
  • Vázquez, Esther|||0000-0003-1052-0424
Cell-selective targeting is expected to enhance effectiveness and minimize side effects of cytotoxic agents. Functionalization of drugs or drug nanoconjugates with specific cell ligands allows receptor-mediated selective cell delivery. However, it is unclear whether the incorporation of an efficient ligand into a drug vehicle is sufficient to ensure proper biodistribution upon systemic administration, and also at which extent biophysical properties of the vehicle may contribute to the accumulation in target tissues during active targeting. To approach this issue, structural robustness of self-assembling, protein-only nanoparticles targeted to the tumoral marker CXCR4 is compromised by reducing the number of histidine residues (from six to five) in a histidine-based architectonic tag. Thus, the structure of the resulting nanoparticles, but not of building blocks, is weakened. Upon intravenous injection in animal models of human CXCR4 colorectal cancer, the administered material loses the ability to accumulate in tumor tissue, where it is only transiently found. It instead deposits in kidney and liver. Therefore, precise cell-targeted delivery requires not only the incorporation of a proper ligand that promotes receptor-mediated internalization, but also, unexpectedly, its maintenance of a stable multimeric nanostructure that ensures high ligand exposure and long residence time in tumor tissue.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Collaborative membrane activity and receptor-dependent tumor cell targeting for precise nanoparticle delivery in CXCR4+ colorectal cancer

  • Sala, Rita
  • Sánchez-García, Laura|||0000-0002-8420-1701
  • Serna, Naroa|||0000-0001-5682-8198
  • Céspedes, María Virtudes|||0000-0003-2956-5833
  • Casanova Rigat, Isolda|||0000-0002-1196-4724
  • Roldán, Mònica
  • Sánchez Chardi, Alejandro|||0000-0002-8789-1883
  • Unzueta Elorza, Ugutz|||0000-0001-5119-2266
  • Vázquez, Esther|||0000-0003-1052-0424
  • Mangues, Ramon|||0000-0003-2661-9525
  • Villaverde, Antonio|||0000-0002-2615-4521
By the appropriate selection of functional peptides and proper accommodation sites, we have generated a set of multifunctional proteins that combine selectivity for CXCR4 cell binding and relevant endosomal escape capabilities linked to the viral peptide HA2. In particular, the construct T22-GFP-HA2-H6 forms nanoparticles that upon administration in mouse models of human, CXCR4 colorectal cancer, accumulates in primary tumor at levels significantly higher than the parental T22-GFP-H6 HA2-lacking version. The in vivo application of a CXCR4 antagonist has confirmed the prevalence of the CXCR4 tumor tissue selectivity over unspecific cell penetration, upon systemic administration of the material. Such specificity is combined with improved endosomal escape, what overall results in a precise and highly efficient tumor biodistribution. These data strongly support the functional recruitment as a convenient approach to generate protein materials for clinical applications. More precisely, they also support the unexpected concept that enhancing the unspecific membrane activity of a protein material does not necessarily compromise, but it can even improve, the selective cell targeting offered by an accompanying functional module. Statement of Significance: We have shown here that the combination of cell-penetrating and tumor cell-targeting peptides dramatically enhances precise tumor accumulation of protein-only nanoparticles intended for selective drug delivery, in mouse models of human colorectal cancer. This fact is a step forward for the rational design of multifunctional protein nanomaterials for improved cancer therapies.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Engineering a nanostructured nucleolin-binding peptide for intracellular drug delivery in triple-negative breast cancer stem cells

  • Pesarrodona Roches, Mireia|||0000-0001-9669-8471
  • Sánchez-García, Laura|||0000-0002-8420-1701
  • Seras-Franzoso, Joaquin|||0000-0002-7893-4773
  • Sánchez Chardi, Alejandro|||0000-0002-8789-1883
  • Baltà Foix, Ricardo
  • Cámara-Sánchez, Patricia|||0000-0003-1958-9735
  • Gener, Petra|||0000-0002-2250-570X
  • Jara, José Juan
  • Pulido, Daniel|||0000-0002-2841-194X
  • Serna, Naroa|||0000-0001-5682-8198
  • Schwartz, Simon|||0000-0001-8297-7971
  • Royo, Miriam|||0000-0001-5292-0819
  • Villaverde, Antonio|||0000-0002-2615-4521
  • Abasolo, Ibane|||0000-0001-5970-6276
  • Vázquez, Esther|||0000-0003-1052-0424
Five peptide ligands of four different cell surface receptors (nucleolin, CXCR1, CMKLR1, and CD44v6) have been evaluated as targeting moieties for triple-negative human breast cancers. Among them, the peptide F3, derived from phage display, promotes the fast and efficient internalization of a genetically fused green fluorescent protein (GFP) inside MDA-MB-231 cancer stem cells in a specific receptor-dependent fashion. The further engineering of this protein into the modular construct F3-RK-GFP-H6 and the subsequent construct F3-RK-PE24-H6 resulted in self-assembling polypeptides that organize as discrete and regular nanoparticles. These materials, 15-20 nm in size, show enhanced nucleolin-dependent cell penetrability. We show that the F3-RK-PE24-H6, based on the Pseudomonas aeruginosa exotoxin A (PE24) as a core functional domain, is highly cytotoxic over target cells. The combination of F3, the cationic peptide (RK), and the toxin domain PE24 in such unusual presentation appears as a promising approach to cell-targeted drug carriers in breast cancers and addresses selective drug delivery in otherwise difficult-to-treat triple-negative breast cancers.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

A refined cocktailing of pro-apoptotic nanoparticles boosts anti-tumor activity

  • Sánchez-García, Laura|||0000-0002-8420-1701
  • Sala, Rita
  • Serna, Naroa|||0000-0001-5682-8198
  • Álamo, Patricia|||0000-0003-0510-5701
  • Parladé, Eloi|||0000-0001-5750-550X
  • Alba Castellón, Lorena|||0000-0003-3449-7820
  • Voltà-Durán, Eric|||0000-0003-0017-8274
  • Sánchez Chardi, Alejandro|||0000-0002-8789-1883
  • Unzueta Elorza, Ugutz|||0000-0001-5119-2266
  • Vázquez, Esther|||0000-0003-1052-0424
  • Mangues, Ramon|||0000-0003-2661-9525
  • Villaverde, Antonio|||0000-0002-2615-4521
A functional 29 amino acid-segment of the helix α5 from the human BAX protein has been engineered for production in recombinant bacteria as self-assembling, GFP-containing fluorescent nanoparticles, which are targeted to the tumoral marker CXCR4. These nanoparticles, of around 34 nm in diameter, show a moderate tumor biodistribution and limited antitumoral effect when systemically administered to mouse models of human CXCR4 colorectal cancer (at 300 μg dose). However, if such BAX nanoparticles are co-administered in cocktail with equivalent nanoparticulate versions of BAK and PUMA proteins at the same total protein dose (300 μg), protein biodistribution and stability in tumor is largely improved, as determined by fluorescence profiles. This fact leads to a potent and faster destruction of tumor tissues when compared to individual pro-apoptotic factors. The analysis and interpretation of the boosted effect, from both the structural and functional sides, offers clues for the design of more efficient nanomedicines and theragnostic agents in oncology based on precise cocktails of human proteins. Statement of significance: Several human pro-apoptotic peptides (namely BAK, BAX and PUMA) have been engineered as self-assembling protein nanoparticles targeted to the tumoral marker CXCR4. The systemic administration of the same final amounts of those materials as single drugs, or as combinations of two or three of them, shows disparate intensities of antitumoral effects in a mouse model of human colorectal cancer, which are boosted in the triple combination on a non-additive basis. The superiority of the combined administration of pro-apoptotic agents, acting at different levels of the apoptotic cascade, opens a plethora of possibilities for the development of effective and selective cancer therapies based on the precise cocktailing of pro-apoptotic nanoparticulate agents. ing Research Center on Bioengineering, Biomaterials and Nanomedicine.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Release of functional fibroblast growth factor-2 from artificial inclusion bodies

  • Serna, Naroa|||0000-0001-5682-8198
  • Cano-Garrido, Olivia|||0000-0002-5504-2131
  • Sánchez, Julieta M.|||0000-0001-6676-5776
  • Sánchez Chardi, Alejandro|||0000-0002-8789-1883
  • Sánchez-García, Laura|||0000-0002-8420-1701
  • López-Laguna, Hèctor|||0000-0001-5249-8304
  • Fernandez, Ester|||0000-0003-0596-7272
  • Villaverde, Antonio|||0000-0002-2615-4521
  • Vázquez, Esther|||0000-0003-1052-0424
Growth factors are required for cell proliferation and differentiation under physiological conditions but especially in the context of regenerative medicine. The time-prolonged administration of those factors has been explored using different sustained drug delivery systems. These platforms include natural materials such as bacterial inclusion bodies (IBs) that contain chaperones and other bacterial components that might favour protein release. Being successful from a functional point of view, IBs pose regulatory concerns to clinical applications because of the mentioned presence of bacterial cell components, including endotoxins. We have here explored the release and activity of the human fibroblast growth factor-2 (hFGF-2) from a novel synthetic material, namely artificial IBs. Being chemically homogenous and compliant with regulatory restrictions, we wondered if these materials would effectively release functional proteins in absence of accompanying bacterial agents. The data provided here fully supports that artificial hFGF-2 IBs act as true and efficient secretory granules and they slowly disintegrate in cell culture to promote wound healing in an in vitro wound healing model. Free from undesired bacterial components, artificial inclusion bodies show promises as delivery agents in regenerative medicine.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Engineering protein nanoparticles out from components of the human microbiome

  • López-Laguna, Hèctor|||0000-0001-5249-8304
  • Sánchez-García, Laura|||0000-0002-8420-1701
  • Serna, Naroa|||0000-0001-5682-8198
  • Voltà-Durán, Eric|||0000-0003-0017-8274
  • Sánchez, Julieta M.|||0000-0001-6676-5776
  • Sánchez Chardi, Alejandro|||0000-0002-8789-1883
  • Unzueta Elorza, Ugutz|||0000-0001-5119-2266
  • Łoś, Marcin
  • Villaverde, Antonio|||0000-0002-2615-4521
  • Vázquez, Esther|||0000-0003-1052-0424
Nanoscale protein materials are highly convenient as vehicles for targeted drug delivery because of their structural and functional versatility. Selective binding to specific cell surface receptors and penetration into target cells require the use of targeting peptides. Such homing stretches should be incorporated to larger proteins that do not interact with body components, to prevent undesired drug release into nontarget organs. Because of their low interactivity with human body components and their tolerated immunogenicity, proteins derived from the human microbiome are appealing and fully biocompatible building blocks for the biofabrication of nonreactive, inert protein materials within the nanoscale. Several phage and phage-like bacterial proteins with natural structural roles are produced in Escherichia coli as polyhistidine-tagged recombinant proteins, looking for their organization as discrete, nanoscale particulate materials. While all of them self-assemble in a variety of sizes, the stability of the resulting constructs at 37 °C is found to be severely compromised. However, the fine adjustment of temperature and Zn concentration allows the formation of robust nanomaterials, fully stable in complex media and under physiological conditions. Then, microbiome-derived proteins show promise for the regulatable construction of scaffold protein nanomaterials, which can be tailored and strengthened by simple physicochemical approaches.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Engineering a recombinant chlorotoxin as cell-targeted cytotoxic nanoparticles

  • Díaz, Raquel
  • Sánchez-García, Laura|||0000-0002-8420-1701
  • Serna, Naroa|||0000-0001-5682-8198
  • Sánchez Chardi, Alejandro|||0000-0002-8789-1883
  • Cano-Garrido, Olivia|||0000-0002-5504-2131
  • Sánchez, Julieta M.|||0000-0001-6676-5776
  • Unzueta Elorza, Ugutz|||0000-0001-5119-2266
  • Vázquez, Esther|||0000-0003-1052-0424
  • Villaverde, Antonio|||0000-0002-2615-4521
The controlled oligomerization of functional proteins at the nanoscale offers the possibility to design and produce, by recombinant DNA technologies and in cell factories, improved materials and drugs in form of nanoparticles. A recombinant version of the scorpion toxin chlorotoxin (CTX), which has attracted interest due to its ability to preferentially bind cancer cells, has been engineered to self-assemble as regular 12 nm-nanoparticles that penetrate cultured cells with the same receptor-specificity than the natural toxin. These materials, that appear as promising, biocompatible and biodegradable drug carriers for cell-targeted therapy of glioma also exhibit a mild but still significant cytotoxic activity associated to the recombinant toxin, that simultaneously acts as both driver and therapeutic agent. In addition, the manipulation of the CTX-flanking regions shows a potent impact on the performance of the nanoparticles, supporting a high functional versatility of CTX-based constructs, regulatable by conventional genetic engineering and adaptable to specific therapeutic situations.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Nanostructured antimicrobial peptides, The last push towards clinics

  • Carratalá, José Vicente|||0000-0001-6950-2939
  • Serna, Naroa|||0000-0001-5682-8198
  • Villaverde, Antonio|||0000-0002-2615-4521
  • Vázquez, Esther|||0000-0003-1052-0424
  • Ferrer-Miralles, Neus|||0000-0003-2981-3913
Peptide drugs hold great potential for the treatment of infectious diseases due to their unconventional mechanisms of action, biocompatibility, biodegradability and ease of synthesis and modification. The increasing rising of bacterial strains resistant to classical antibiotics have pushed the development of new peptide-based antimicrobial therapies. In this context, over the past few years, different approaches have reached a clinical approval. Furthermore, the application of nanotechnological principles to the design of antimicrobial peptide-based composites increases even more the already known benefits of antimicrobial peptides as competent protein drugs. Then, we provide here an overview of the current strategies for antimicrobial peptide discovery and modification and the status of such peptides already under clinical development. In addition, we summarize the innovative formulation strategies for their application, focusing on the controlled self-assembly for the fabrication of antimicrobial nanostructures without the assistance of external nanocarriers, and with emphasis on bioengineering, design of ultra-short peptides and rising insights in bacterial selectivity.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Engineering secretory amyloids for remote and highly selective destruction of metastatic foci

  • Céspedes, María Virtudes|||0000-0003-2956-5833
  • Cano-Garrido, Olivia|||0000-0002-5504-2131
  • Álamo, Patricia|||0000-0003-0510-5701
  • Sala, Rita
  • Gallardo, Alberto|||0000-0002-2514-2027
  • Serna, Naroa|||0000-0001-5682-8198
  • Falgàs, Aïda|||0000-0002-5040-2265
  • Voltà-Durán, Eric|||0000-0003-0017-8274
  • Casanova Rigat, Isolda|||0000-0002-1196-4724
  • Sánchez Chardi, Alejandro|||0000-0002-8789-1883
  • López-Laguna, Hèctor|||0000-0001-5249-8304
  • Sánchez-García, Laura|||0000-0002-8420-1701
  • Sánchez, Julieta M.|||0000-0001-6676-5776
  • Unzueta Elorza, Ugutz|||0000-0001-5119-2266
  • Vázquez, Esther|||0000-0003-1052-0424
  • Mangues, Ramon|||0000-0003-2661-9525
  • Villaverde, Antonio|||0000-0002-2615-4521
Functional amyloids produced in bacteria as nanoscale inclusion bodies are intriguing but poorly explored protein materials with wide therapeutic potential. Since they release functional polypeptides under physiological conditions, these materials can be potentially tailored as mimetic of secretory granules for slow systemic delivery of smart protein drugs. To explore this possibility, bacterial inclusion bodies formed by a self-assembled, tumor-targeted Pseudomonas exotoxin (PE24) are administered subcutaneously in mouse models of human metastatic colorectal cancer, for sustained secretion of tumor-targeted therapeutic nanoparticles. These proteins are functionalized with a peptidic ligand of CXCR4, a chemokine receptor overexpressed in metastatic cancer stem cells that confers high selective cytotoxicity in vitro and in vivo. In the mouse models of human colorectal cancer, time-deferred anticancer activity is detected after the subcutaneous deposition of 500 µg of PE24-based amyloids, which promotes a dramatic arrest of tumor growth in the absence of side toxicity. In addition, long-term prevention of lymphatic, hematogenous, and peritoneal metastases is achieved. These results reveal the biomedical potential and versatility of bacterial inclusion bodies as novel tunable secretory materials usable in delivery, and they also instruct how therapeutic proteins, even with high functional and structural complexity, can be packaged in this convenient format.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Fluorescent dye labeling changes the biodistribution of cell-targeted nanoparticles

  • Álamo, Patricia|||0000-0003-0510-5701
  • Pallarès, Victor|||0000-0002-9851-0345
  • Céspedes, María Virtudes|||0000-0003-2956-5833
  • Falgàs, Aïda|||0000-0002-5040-2265
  • Sánchez, Julieta M.|||0000-0001-6676-5776
  • Serna, Naroa|||0000-0001-5682-8198
  • Sánchez-García, Laura|||0000-0002-8420-1701
  • Voltà-Durán, Eric|||0000-0003-0017-8274
  • Morris, Gordon A.|||0000-0003-2588-6349
  • Sánchez Chardi, Alejandro|||0000-0002-8789-1883
  • Casanova Rigat, Isolda|||0000-0002-1196-4724
  • Mangues, Ramon|||0000-0003-2661-9525
  • Vázquez, Esther|||0000-0003-1052-0424
  • Villaverde, Antonio|||0000-0002-2615-4521
  • Unzueta Elorza, Ugutz|||0000-0001-5119-2266
Fluorescent dye labeling is a common strategy to analyze the fate of administered nanoparticles in living organisms. However, to which extent the labeling processes can alter the original nanoparticle biodistribution has been so far neglected. In this work, two widely used fluorescent dye molecules, namely, ATTO488 (ATTO) and Sulfo-Cy5 (S-Cy5), have been covalently attached to a well-characterized CXCR4-targeted self-assembling protein nanoparticle (known as T22-GFP-H6). The biodistribution of labeled T22-GFP-H6-ATTO and T22-GFP-H6-S-Cy5 nanoparticles has been then compared to that of the non-labeled nanoparticle in different CXCR4+ tumor mouse models. We observed that while parental T22-GFP-H6 nanoparticles accumulated mostly and specifically in CXCR4+ tumor cells, labeled T22-GFP-H6-ATTO and T22-GFP-H6-S-Cy5 nanoparticles showed a dramatic change in the biodistribution pattern, accumulating in non-target organs such as liver or kidney while reducing tumor targeting capacity. Therefore, the use of such labeling molecules should be avoided in target and non-target tissue uptake studies during the design and development of targeted nanoscale drug delivery systems, since their effect over the fate of the nanomaterial can lead to considerable miss-interpretations of the actual nanoparticle biodistribution.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Design and engineering of tumor-targeted, dual-acting cytotoxic nanoparticles

  • Voltà-Durán, Eric|||0000-0003-0017-8274
  • Serna, Naroa|||0000-0001-5682-8198
  • Sánchez-García, Laura|||0000-0002-8420-1701
  • Aviñó, Ana|||0000-0003-3047-738X
  • Sánchez, Julieta M.|||0000-0001-6676-5776
  • López-Laguna, Hèctor|||0000-0001-5249-8304
  • Cano-Garrido, Olivia|||0000-0002-5504-2131
  • Casanova Rigat, Isolda|||0000-0002-1196-4724
  • Mangues, Ramon|||0000-0003-2661-9525
  • Eritja, Ramon|||0000-0001-5383-9334
  • Vázquez, Esther|||0000-0003-1052-0424
  • Villaverde, Antonio|||0000-0002-2615-4521
  • Unzueta Elorza, Ugutz|||0000-0001-5119-2266
The possibility to conjugate tumor-targeted cytotoxic nanoparticles and conventional antitumoral drugs in single pharmacological entities would open a wide spectrum of opportunities in nanomedical oncology. This principle has been explored here by using CXCR4-targeted self-assembling protein nanoparticles based on two potent microbial toxins, the exotoxin A from Pseudomonas aeruginosa and the diphtheria toxin from Corynebacterium diphtheriae, to which oligo-floxuridine and monomethyl auristatin E respectively have been chemically coupled. The resulting multifunctional hybrid nanoconjugates, with a hydrodynamic size of around 50 nm, are stable and internalize target cells with a biological impact. Although the chemical conjugation minimizes the cytotoxic activity of the protein partner in the complexes, the concept of drug combination proposed here is fully feasible and highly promising when considering multiple drug treatments aimed to higher effectiveness or when facing the therapy of cancers with acquired resistance to classical drugs.
Dipòsit Digital de Documents de la UAB
Research data Set de datos (Dataset)

Analysis of EPI-X4 binding to CXCR4, raw data to be linked to a scientific publication

  • Cano-Garrido, Olivia|||0000-0002-5504-2131
  • Álamo, Patricia|||0000-0003-0510-5701
  • Sánchez-García, Laura|||0000-0002-8420-1701
  • Falgàs, Aïda|||0000-0002-5040-2265
  • Sánchez Chardi, Alejandro|||0000-0002-8789-1883
  • Serna, Naroa|||0000-0001-5682-8198
  • Parladé, Eloi|||0000-0001-5750-550X
  • Unzueta Elorza, Ugutz|||0000-0001-5119-2266
  • Roldán, Mònica
  • Voltà-Durán, Eric|||0000-0003-0017-8274
  • Casanova Rigat, Isolda|||0000-0002-1196-4724
  • Villaverde, Antonio|||0000-0002-2615-4521
  • Mangues, Ramon|||0000-0003-2661-9525
  • Vázquez, Esther|||0000-0003-1052-0424
This data set contains several Excel files with raw data from a complex set of experiments aiming at exploring the interactivity of EPI-X4 and CXCR4+ cells. Only numerical data from those experimental is included here.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Biparatopic protein nanoparticles for the precision therapy of cxcr4+ cancers

  • Cano-Garrido, Olivia|||0000-0002-5504-2131
  • Álamo, Patricia|||0000-0003-0510-5701
  • Sánchez-García, Laura|||0000-0002-8420-1701
  • Falgàs, Aïda|||0000-0002-5040-2265
  • Sánchez Chardi, Alejandro|||0000-0002-8789-1883
  • Serna, Naroa|||0000-0001-5682-8198
  • Parladé, Eloi|||0000-0001-5750-550X
  • Unzueta Elorza, Ugutz|||0000-0001-5119-2266
  • Roldán, Mònica
  • Voltà-Durán, Eric|||0000-0003-0017-8274
  • Casanova Rigat, Isolda|||0000-0002-1196-4724
  • Villaverde, Antonio|||0000-0002-2615-4521
  • Mangues, Ramon|||0000-0003-2661-9525
  • Vázquez, Esther|||0000-0003-1052-0424
The accumulated molecular knowledge about human cancer enables the identification of multiple cell surface markers as highly specific therapeutic targets. A proper tumor targeting could significantly avoid drug exposure of healthy cells, minimizing side effects, but it is also expected to increase the therapeutic index. Specifically, colorectal cancer has a particularly poor prognosis in late stages, being drug targeting an appropriate strategy to substantially improve the therapeutic efficacy. In this study, we have explored the potential of the human albumin-derived peptide, EPI-X4, as a suitable ligand to target colorectal cancer via the cell surface protein CXCR4, a chemokine receptor overexpressed in cancer stem cells. To explore the potential use of this ligand, self-assem-bling protein nanoparticles have been generated displaying an engineered EPI-X4 version, which conferred a modest CXCR4 targeting and fast and high level of cell apoptosis in tumor CXCR4 cells, in vitro and in vivo. In addition, when EPI-X4-based building blocks are combined with biologically inert polypeptides containing the CXCR4 ligand T22, the resulting biparatopic nanoparticles show a dramatically improved biodistribution in mouse models of CXCR4 human cancer, faster cell internalization and enhanced target cell death when compared to the version based on a single ligand. The generation of biparatopic materials opens exciting possibilities in oncotherapies based on high precision drug delivery based on the receptor CXCR4.
Dipòsit Digital de Documents de la UAB
Research data Set de datos (Dataset)

Raw data to support the manuscript "The spectrum of building block conformers sustains the biophysical properties of clinically-oriented, self-assembling protein nanoparticles"

  • Voltà-Durán, Eric|||0000-0003-0017-8274
  • Sánchez, Julieta M.|||0000-0001-6676-5776
  • López-Laguna, Hèctor|||0000-0001-5249-8304
  • Parladé, Eloi|||0000-0001-5750-550X
  • Sánchez-García, Laura|||0000-0002-8420-1701
  • Sánchez Chardi, Alejandro|||0000-0002-8789-1883
  • de Marco, Ario|||0000-0001-7729-819X
  • Unzueta Elorza, Ugutz|||0000-0001-5119-2266
  • Vázquez, Esther|||0000-0003-1052-0424
  • Villaverde, Antonio|||0000-0002-2615-4521
Raw data of a set of experiments aimed to explore the impact of protein conformation on the structural variability of resulting self-assembling materials.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Biofabrication of functional protein nanoparticles through simple His-tag engineering

  • López-Laguna, Hèctor|||0000-0001-5249-8304
  • Sánchez, Julieta M.|||0000-0001-6676-5776
  • Carratalá, José Vicente|||0000-0001-6950-2939
  • Rojas Peña, Mauricio|||0000-0002-2373-1792
  • Sánchez-García, Laura|||0000-0002-8420-1701
  • Parladé, Eloi|||0000-0001-5750-550X
  • Sánchez Chardi, Alejandro|||0000-0002-8789-1883
  • Voltà-Durán, Eric|||0000-0003-0017-8274
  • Serna, Naroa|||0000-0001-5682-8198
  • Cano-Garrido, Olivia|||0000-0002-5504-2131
  • Flores, Sandra
  • Ferrer-Miralles, Neus|||0000-0003-2981-3913
  • Nolan, Verónica
  • de Marco, Ario|||0000-0001-7729-819X
  • Roher Armentia, Nerea|||0000-0002-6659-4038
  • Unzueta Elorza, Ugutz|||0000-0001-5119-2266
  • Vázquez, Esther|||0000-0003-1052-0424
  • Villaverde, Antonio|||0000-0002-2615-4521
We have developed a simple, robust, and fully transversal approach for thea-la-cartefabrication of functional multimeric nanoparticles with potential biomedical applications, validated here by a set of diverse and unrelated polypeptides. The proposed concept is based on the controlled coordination between Znions and His residues in His-tagged proteins. This approach results in a spontaneous and reproducible protein assembly as nanoscale oligomers that keep the original functionalities of the protein building blocks. The assembly of these materials is not linked to particular polypeptide features, and it is based on an environmentally friendly and sustainable approach. The resulting nanoparticles, with dimensions ranging between 10 and 15 nm, are regular in size, are architecturally stable, are fully functional, and serve as intermediates in a more complex assembly process, resulting in the formation of microscale protein materials. Since most of the recombinant proteins produced by biochemical and biotechnological industries and intended for biomedical research are His-tagged, the green biofabrication procedure proposed here can be straightforwardly applied to a huge spectrum of protein species for their conversion into their respective nanostructured formats.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Evaluation of the integration of P recovery, polyhydroxyalkanoate production and short cut nitrogen removal in a mainstream wastewater treatment process

  • Larriba, Oriol|||0000-0002-7407-6185
  • Rovira-Cal, Eric
  • Juznic-Zonta, Zivko|||0000-0002-2362-9771
  • Guisasola, Albert|||0000-0002-3012-7964
  • Baeza, Juan Antonio|||0000-0003-1290-1669
Wastewater treatment systems are nowadays evolving into systems where energy and resources are recovered from wastewater. This work presents the long term operation of a demo-scale pilot plant (7.8 m(3)) with a novel configuration named as mainstream SCEPPHAR (ShortCut Enhanced Phosphorus and polyhydroxyalkanoate (PHA) Recovery) and based on two sequencing batch reactors (R1-HET and R2-AUT). This is the first report of an implementation at demo scale and under relevant operational conditions of the simultaneous integration of shortcut nitrification, P recovery and production of sludge with a higher PHA content than conventional activated sludge. An operating period under full nitrification mode achieved successful removal efficiencies for total N, P and CODT (86 +/- 12%, 93 +/- 9% and 79 +/- 6%). In the following period, nitrite shortcut (with undetectable activity of nitrite oxidising bacteria) was achieved by implementing automatic control of the aerobic phase length in R2-AUT using ammonium measurement andoperating at a lower sludge retention time. Similar N, P and CODT removal efficiencies to the full nitrification period were obtained. P-recovery from the anaerobic supernatant of R1-HET was achieved in a separate precipitator by increasing pH and dosing MgCl2, recovering an average value of 45% of the P in the influent as struvite precipitate, with a peak up to 63%. These values are much higher than the typical values of sidestream P-recovery (12%). Regarding PHA, a percentage in the biomass in the range 6.9-9.2% (gPHA.g(-1)TSS) was obtained.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

The spectrum of building block conformers sustains the biophysical properties of clinically-oriented self-assembling protein nanoparticles

  • Voltà-Durán, Eric|||0000-0003-0017-8274
  • Sánchez, Julieta M.|||0000-0001-6676-5776
  • López-Laguna, Hèctor|||0000-0001-5249-8304
  • Parladé, Eloi|||0000-0001-5750-550X
  • Sánchez-García, Laura|||0000-0002-8420-1701
  • Sánchez Chardi, Alejandro|||0000-0002-8789-1883
  • de Marco, Ario|||0000-0001-7729-819X
  • Unzueta Elorza, Ugutz|||0000-0001-5119-2266
  • Vázquez, Esther|||0000-0003-1052-0424
  • Villaverde, Antonio|||0000-0002-2615-4521
Histidine-rich peptides confer self-assembling properties to recombinant proteins through the supramolecular coordination with divalent cations. This fact allows the cost-effective, large-scale generation of microscopic and macroscopic protein materials with intriguing biomedical properties. Among such materials, resulting from the simple bioproduction of protein building blocks, homomeric nanoparticles are of special value as multivalent interactors and drug carriers. Interestingly, we have here identified that the assembly of a given His-tagged protein might render distinguishable categories of self-assembling protein nanoparticles. This fact has been scrutinized through the nanobody-containing fusion proteins EM1-GFP-H6 and A3C8-GFP-H6, whose biosynthesis results in two distinguishable populations of building blocks. In one of them, the assembling and disassembling is controllable by cations. However, a second population immediately self-assembles upon purification through a non-regulatable pathway, rendering larger nanoparticles with specific biological properties. The structural analyses of both model proteins and nanoparticles revealed important conformational variability in the building blocks. This fact renders different structural and functional categories of the final soft materials resulting from the participation of energetically unstable intermediates in the oligomerization process. These data illustrate the complexity of the His-mediated protein assembling in recombinant proteins but they also offer clues for a better design and refinement of protein-based nanomedicines, which, resulting from biological fabrication, show an architectonic flexibility unusual among biomaterials.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

A Computational Model of the Fetal Circulation to Quantify Blood Redistribution in Intrauterine Growth Restriction

  • Garcia-Canadilla, Patricia
  • Rudenick, Paula A.|||0000-0003-0561-0193
  • Crispi, Fatima|||0000-0002-7422-5240
  • Cruz-Lemini, Monica|||0000-0002-6807-3578
  • Palau, Georgina
  • Camara, Oscar|||0000-0002-5125-6132
  • Gratacós, Eduard|||0000-0002-7405-7224
  • Bijens, Bart H.
Intrauterine growth restriction (IUGR) due to placental insufficiency is associated with blood flow redistribution in order to maintain delivery of oxygenated blood to the brain. Given that, in the fetus the aortic isthmus (AoI) is a key arterial connection between the cerebral and placental circulations, quantifying AoI blood flow has been proposed to assess this brain sparing effect in clinical practice. While numerous clinical studies have studied this parameter, fundamental understanding of its determinant factors and its quantitative relation with other aspects of haemodynamic remodeling has been limited. Computational models of the cardiovascular circulation have been proposed for exactly this purpose since they allow both for studying the contributions from isolated parameters as well as estimating properties that cannot be directly assessed from clinical measurements. Therefore, a computational model of the fetal circulation was developed, including the key elements related to fetal blood redistribution and using measured cardiac outflow profiles to allow personalization. The model was first calibrated using patient-specific Doppler data from a healthy fetus. Next, in order to understand the contributions of the main parameters determining blood redistribution, AoI and middle cerebral artery (MCA) flow changes were studied by variation of cerebral and peripheral-placental resistances. Finally, to study how this affects an individual fetus, the model was fitted to three IUGR cases with different degrees of severity. In conclusion, the proposed computational model provides a good approximation to assess blood flow changes in the fetal circulation. The results support that while MCA flow is mainly determined by a fall in brain resistance, the AoI is influenced by a balance between increased peripheral-placental and decreased cerebral resistances. Personalizing the model allows for quantifying the balance between cerebral and peripheral-placental remodeling, thus providing potentially novel information to aid clinical follow up. Intrauterine growth restriction (IUGR) is one of the leading causes of perinatal mortality and can be defined as a low birth weight together with signs of chronic hypoxia or malnutrition. It is mostly due to placental insufficiency resulting in a chronic restriction of oxygen and nutrients to the fetus. IUGR leads to cardiac dysfunction in utero which can persist postnatally. Under these altered conditions, IUGR fetuses redistribute their blood in order to maintain delivery of oxygenated blood to the brain, known as brain sparing. Given that, in the fetus the aortic isthmus (AoI) is a key arterial connection between the cerebral and placental circulations, quantifying AoI blood flow has been proposed to assess this brain sparing effect in clinical practice. However, which remodeling or redistribution processes in the cardiovascular systems induce the observed changes in AoI flow in IUGR fetuses is not fully understood. We developed a computational model of the fetal circulation, including the key elements related to fetal blood redistribution. Using measured cardiac outflow profiles to allow personalization, we can recreate and better understand the blood flow changes in individual IUGR fetuses.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

CXCR4-targeted nanotoxins induce GSDME-dependent pyroptosis in head and neck squamous cell carcinoma

  • Rioja Blanco, Elisa|||0000-0003-4176-8772
  • Arroyo Solera, Irene|||0000-0003-0425-1483
  • Álamo, Patricia|||0000-0003-0510-5701
  • Casanova Rigat, Isolda|||0000-0002-1196-4724
  • Gallardo, Alberto|||0000-0002-2514-2027
  • Unzueta Elorza, Ugutz|||0000-0001-5119-2266
  • Serna, Naroa|||0000-0001-5682-8198
  • Sánchez-García, Laura|||0000-0002-8420-1701
  • Quer, Miquel|||0000-0003-2563-6729
  • Villaverde, Antonio|||0000-0002-2615-4521
  • Vázquez, Esther|||0000-0003-1052-0424
  • León i Vintró, Xavier|||0000-0001-6286-630X
  • Alba Castellón, Lorena|||0000-0003-3449-7820
  • Mangues, Ramon|||0000-0003-2661-9525
Therapy resistance, which leads to the development of loco-regional relapses and distant metastases after treatment, constitutes one of the major problems that head and neck squamous cell carcinoma (HNSCC) patients currently face. Thus, novel therapeutic strategies are urgently needed. Targeted drug delivery to the chemokine receptor 4 (CXCR4) represents a promising approach for HNSCC management. In this context, we have developed the self-assembling protein nanotoxins T22-PE24-H6 and T22-DITOX-H6, which incorporate the de-immunized catalytic domain of Pseudomonas aeruginosa (PE24) exotoxin A and the diphtheria exotoxin (DITOX) domain, respectively. Both nanotoxins contain the T22 peptide ligand to specifically target CXCR4-overexpressing HNSCC cells. In this study, we evaluate the potential use of T22-PE24-H6 and T22-DITOX-H6 nanotoxins for the treatment of HNSCC. T22-PE24-H6 and T22-DITOX-H6 CXCR4-dependent cytotoxic effect was evaluated in vitro in two different HNSCC cell lines. Both nanotoxins cell death mechanisms were assessed in HNSCC cell lines by phase-contrast microscopy, AnnexinV/ propidium iodide (PI) staining, lactate dehydrogenase (LDH) release assays, and western blotting. Nanotoxins antitumor effect in vivo was studied in a CXCR4 + HNSCC subcutaneous mouse model. Immunohistochemistry, histopathology, and toxicity analyses were used to evaluate both nanotoxins antitumor effect and possible treatment toxicity. GSMDE and CXCR4 expression in HNSCC patient tumor samples was also assessed by immunohistochemical staining. First, we found that both nanotoxins exhibit a potent CXCR4-dependent cytotoxic effect in vitro. Importantly, nanotoxin treatment triggered caspase-3/Gasdermin E (GSDME)-mediated pyroptosis. The activation of this alternative cell death pathway that differs from traditional apoptosis, becomes a promising strategy to bypass therapy resistance. In addition, T22-PE24-H6 and T22-DITOX-H6 displayed a potent antitumor effect in the absence of systemic toxicity in a CXCR4 + subcutaneous HNSCC mouse model. Lastly, GSDME was found to be overexpressed in tumor tissue from HNSCC patients, highlighting the relevance of this strategy. Altogether, our results show that T22-PE24-H6 and T22-DITOX-H6 represent a promising therapy for HNSCC patients. Remarkably, this is the first study showing that both nanotoxins are capable of activating caspase-3/GSDME-dependent pyroptosis, opening a novel avenue for HNSCC treatment. The online version contains supplementary material available at 10.1186/s13046-022-02267-8.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

A Novel CXCR4-Targeted Diphtheria Toxin Nanoparticle Inhibits Invasion and Metastatic Dissemination in a Head and Neck Squamous Cell Carcinoma Mouse Model

  • Rioja Blanco, Elisa|||0000-0003-4176-8772
  • Gallardo, Alberto|||0000-0002-2514-2027
  • Arroyo Solera, Irene|||0000-0003-0425-1483
  • Álamo, Patricia|||0000-0003-0510-5701
  • Casanova Rigat, Isolda|||0000-0002-1196-4724
  • Unzueta Elorza, Ugutz|||0000-0001-5119-2266
  • Serna, Naroa|||0000-0001-5682-8198
  • Sánchez-García, Laura|||0000-0002-8420-1701
  • Quer, Miquel|||0000-0003-2563-6729
  • Villaverde, Antonio|||0000-0002-2615-4521
  • Vázquez, Esther|||0000-0003-1052-0424
  • León i Vintró, Xavier|||0000-0001-6286-630X
  • Alba Castellón, Lorena|||0000-0003-3449-7820
  • Mangues, Ramon|||0000-0003-2661-9525
Loco-regional recurrences and metastasis represent the leading causes of death in head and neck squamous cell carcinoma (HNSCC) patients, highlighting the need for novel therapies. Chemokine receptor 4 (CXCR4) has been related to loco-regional and distant recurrence and worse patient prognosis. In this regard, we developed a novel protein nanoparticle, T22-DITOX-H6, aiming to selectively deliver the diphtheria toxin cytotoxic domain to CXCR4+ HNSCC cells. The antimetastatic effect of T22-DITOX-H6 was evaluated in vivo in an orthotopic mouse model. IVIS imaging system was utilized to assess the metastatic dissemination in the mouse model. Immunohistochemistry and histopathological analyses were used to study the CXCR4 expression in the cancer cells, to evaluate the effect of the nanotoxin treatment, and its potential off-target toxicity. In this study, we report that CXCR4+ cancer cells were present in the invasive tumor front in an orthotopic mouse model. Upon repeated T22-DITOX-H6 administration, the number of CXCR4+ cancer cells was significantly reduced. Similarly, nanotoxin treatment effectively blocked regional and distant metastatic dissemination in the absence of systemic toxicity in the metastatic HNSCC mouse model. The repeated administration of T22-DITOX-H6 clearly abrogates tumor invasiveness and metastatic dissemination without inducing any off-target toxicity. Thus, T22-DITOX-H6 holds great promise for the treatment of CXCR4+ HNSCC patients presenting worse prognosis.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Self-assembling protein nanocarrier for selective delivery of cytotoxic polypeptides to CXCR4 + head and neck squamous cell carcinoma tumors

  • Rioja Blanco, Elisa|||0000-0003-4176-8772
  • Arroyo Solera, Irene|||0000-0003-0425-1483
  • Álamo, Patricia|||0000-0003-0510-5701
  • Casanova Rigat, Isolda|||0000-0002-1196-4724
  • Gallardo, Alberto|||0000-0002-2514-2027
  • Unzueta Elorza, Ugutz|||0000-0001-5119-2266
  • Serna, Naroa|||0000-0001-5682-8198
  • Sánchez-García, Laura|||0000-0002-8420-1701
  • Quer, Miquel|||0000-0003-2563-6729
  • Villaverde, Antonio|||0000-0002-2615-4521
  • Vázquez, Esther|||0000-0003-1052-0424
  • Mangues, Ramon|||0000-0003-2661-9525
  • Alba Castellón, Lorena|||0000-0003-3449-7820
  • León i Vintró, Xavier|||0000-0001-6286-630X
Loco-regional recurrences and distant metastases represent the main cause of head and neck squamous cell carcinoma (HNSCC) mortality. The overexpression of chemokine receptor 4 (CXCR4) in HNSCC primary tumors associates with higher risk of developing loco-regional recurrences and distant metastases, thus making CXCR4 an ideal entry pathway for targeted drug delivery. In this context, our group has generated the self-assembling protein nanocarrier T22-GFP-H6, displaying multiple T22 peptidic ligands that specifically target CXCR4. This study aimed to validate T22-GFP-H6 as a suitable nanocarrier to selectively deliver cytotoxic agents to CXCR4 + tumors in a HNSCC model. Here we demonstrate that T22-GFP-H6 selectively internalizes in CXCR4 + HNSCC cells, achieving a high accumulation in CXCR4 + tumors in vivo, while showing negligible nanocarrier distribution in non-tumor bearing organs. Moreover, this T22-empowered nanocarrier can incorporate bacterial toxin domains to generate therapeutic nanotoxins that induce cell death in CXCR4-overexpressing tumors in the absence of histological alterations in normal organs. Altogether, these results show the potential use of this T22-empowered nanocarrier platform to incorporate polypeptidic domains of choice to selectively eliminate CXCR4 + cells in HNSCC. Remarkably, to our knowledge, this is the first study testing targeted protein-only nanoparticles in this cancer type, which may represent a novel treatment approach for HNSCC patients. The self-assembling protein nanocarrier T22-GFP-H6, that specifically targets CXCR4, was designed to selectively deliver cytotoxic agents to CXCR4 + tumors in a head and neck squamous cell carcinoma model.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

A multivalent Ara-C-prodrug nanoconjugate achieves selective ablation of leukemic cells in an acute myeloid leukemia mouse model

  • Pallarès, Victor|||0000-0002-9851-0345
  • Unzueta Elorza, Ugutz|||0000-0001-5119-2266
  • Falgàs, Aïda|||0000-0002-5040-2265
  • Aviñó, Ana|||0000-0003-3047-738X
  • Núñez, Yáiza|||0000-0001-7268-2125
  • Garcia León, Annabel|||0000-0003-3007-9306
  • Sánchez-García, Laura|||0000-0002-8420-1701
  • Serna, Naroa|||0000-0001-5682-8198
  • Gallardo, Alberto|||0000-0002-2514-2027
  • Alba Castellón, Lorena|||0000-0003-3449-7820
  • Álamo, Patricia|||0000-0003-0510-5701
  • Sierra, Jorge|||0000-0002-7966-0356
  • Cedó, Lídia|||0000-0003-4354-3411
  • Eritja, Ramon|||0000-0001-5383-9334
  • Villaverde, Antonio|||0000-0002-2615-4521
  • Vázquez, Esther|||0000-0003-1052-0424
  • Casanova Rigat, Isolda|||0000-0002-1196-4724
  • Mangues, Ramon|||0000-0003-2661-9525
Current therapy in acute myeloid leukemia (AML) is based on chemotherapeutic drugs administered at high doses, lacking targeting selectivity and displaying poor therapeutic index because of severe adverse effects. Here, we develop a novel nanoconjugate that combines a self-assembled, multivalent protein nanoparticle, targeting the CXCR4 receptor, with an Oligo-Ara-C prodrug, a pentameric form of Ara-C, to highly increase the delivered payload to target cells. This 13.4 nm T22-GFP-H6-Ara-C nanoconjugate selectively eliminates CXCR4 AML cells, which are protected by its anchoring to the bone marrow (BM) niche, being involved in AML progression and chemotherapy resistance. This nanoconjugate shows CXCR4-dependent internalization and antineoplastic activity in CXCR4 AML cells in vitro. Moreover, repeated T22-GFP-H6-Ara-C administration selectively eliminates CXCR4 leukemic cells in BM, spleen and liver. The leukemic dissemination blockage induced by T22-GFP-H6-Ara-C is significantly more potent than buffer or Oligo-Ara-C-treated mice, showing no associated on-target or off-target toxicity and, therefore, reaching a highly therapeutic window. In conclusion, T22-GFP-H6-Ara-C exploits its 11 ligands-multivalency to enhance target selectivity, while the Oligo-Ara-C prodrug multimeric form increases 5-fold its payload. This feature combination offers an alternative nanomedicine with higher activity and greater tolerability than current intensive or non-intensive chemotherapy for AML patients.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Self-assembled nanobodies as selectively targeted, nanostructured, and multivalent materials

  • Sánchez-García, Laura|||0000-0002-8420-1701
  • Voltà-Durán, Eric|||0000-0003-0017-8274
  • Parladé, Eloi|||0000-0001-5750-550X
  • Mazzega, Elisa
  • Sánchez Chardi, Alejandro|||0000-0002-8789-1883
  • Serna, Naroa|||0000-0001-5682-8198
  • López-Laguna, Hèctor|||0000-0001-5249-8304
  • Mitstorfer, Mara
  • Unzueta Elorza, Ugutz|||0000-0001-5119-2266
  • Vázquez, Esther|||0000-0003-1052-0424
  • Villaverde, Antonio|||0000-0002-2615-4521
  • de Marco, Ario|||0000-0001-7729-819X
Nanobodies represent valuable tools in advanced therapeutic strategies but their small size (∼2.5 × ∼ 4 nm) and limited valence for interactions might pose restrictions for in vivo applications, especially regarding their modest capacity for multivalent and cooperative interaction. In this work, modular protein constructs have been designed, in which nanobodies are fused to protein domains to provide further functionalities and to favor oligomerization into stable self-assembled nanoparticles. The nanobody specificity for their targets is maintained in such supramolecular complexes. Also, their diameter around 70 nm and multivalent interactivity should favor binding and penetrability into target cells via solvent-exposed receptor. These concepts have been supported by unrelated nanobodies directed against the ricin toxin (A3C8) and the Her2 receptor (EM1), respectively, that were modified with the addition of a reporter protein and a hexa-histidine tag at the C-terminus that promotes self-assembling. The A3C8-based nanoparticles neutralize the ricin toxin efficiently, whereas the EM1-based nanoparticles enable to selective imaging Her2-positive cells. These findings support the excellent extracellular and intracellular functionality of nanobodies organized in form of oligomeric nanoscale assemblies.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

In vitro fabrication of microscale secretory granules

  • López-Laguna, Hèctor|||0000-0001-5249-8304
  • Parladé, Eloi|||0000-0001-5750-550X
  • Álamo, Patricia|||0000-0003-0510-5701
  • Sánchez, Julieta M.|||0000-0001-6676-5776
  • Voltà-Durán, Eric|||0000-0003-0017-8274
  • Serna, Naroa|||0000-0001-5682-8198
  • Sánchez-García, Laura|||0000-0002-8420-1701
  • Cano-Garrido, Olivia|||0000-0002-5504-2131
  • Sánchez Chardi, Alejandro|||0000-0002-8789-1883
  • Villaverde, Antonio|||0000-0002-2615-4521
  • Mangues, Ramon|||0000-0003-2661-9525
  • Unzueta Elorza, Ugutz|||0000-0001-5119-2266
  • Vázquez, Esther|||0000-0003-1052-0424
Advanced medical treatments involving drug delivery require fully biocompatible materials with the ability to release functional drugs in a time-prolonged way. Ideally, the delivered molecules should be self-contained as chemically homogenous entities to prevent the use of potentially toxic scaffolds or hold matrices. In nature, peptidic hormones are self-stored in protein-only secretory granules formed by the reversible coordination of Zn and histidine residues. Inspired by this concept, an in vitro transversal procedure is developed, analyzed, and comparatively applied for the fabrication of protein-only secretory granules at the microscale. These materials can be produced from any polyhistidine-tagged protein using physiological concentrations of Zn as a potent and versatile glue-like agent. The screening of granules formed by 12 engineered and nonengineered proteins at different Zn concentrations revealed optimal fabrication conditions and the consequent release profiles. Moreover, the functional and structural properties of the delivered protein are fully validated using a drug-targeting protein platform in a mouse model of human colorectal cancer. In summary, short histidine tags allow the packaging of structurally and functionally dissimilar polypeptides, which supports the proposed fabrication method as a powerful protocol extensible to diverse clinical scenarios in which slow protein drug delivery is required.
Dipòsit Digital de Documents de la UAB
Research data Set de datos (Dataset)

Raw data from Self-Assembled Nanobodies as Selectively Targeted, Nanostructured and Multivalent Materials

  • Sánchez-García, Laura|||0000-0002-8420-1701
  • Voltà-Durán, Eric|||0000-0003-0017-8274
  • Parladé, Eloi|||0000-0001-5750-550X
  • Mazzega, Elisa
  • Sánchez Chardi, Alejandro|||0000-0002-8789-1883
  • Serna, Naroa|||0000-0001-5682-8198
  • López-Laguna, Hèctor|||0000-0001-5249-8304
  • Mitstorfer, Mara
  • Unzueta Elorza, Ugutz|||0000-0001-5119-2266
  • Vázquez, Esther|||0000-0003-1052-0424
  • Villaverde, Antonio|||0000-0002-2615-4521
  • de Marco, Ario|||0000-0001-7729-819X
Raw data of a set of experiments aimed to explore the self-assembling of recombinant nanobodies.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Pretreatment tissue TCR repertoire evenness is associated with complete pathologic response in patients with NSCLC receiving neoadjuvant chemoimmunotherapy

  • Casarrubios, Marta|||0000-0002-2872-9552
  • Cruz-Bermúdez, Alberto|||0000-0001-5136-7011
  • Nadal, Ernest|||0000-0002-9674-5554
  • Insa, Amelia|||0000-0002-3438-6170
  • García Campelo, María del Rosario
  • Lázaro, Martín|||0000-0002-0657-4713
  • Dómine Gómez, Manuel|||0000-0003-1634-9832
  • Majem Tarruella, Margarita|||0000-0002-9919-7485
  • Rodríguez-Abreu, Delvys|||0000-0003-0506-1366
  • Martinez-Marti, Alex|||0000-0002-6714-9526
  • Castro, Javier de|||0000-0002-3622-6306
  • Cobo, Manuel|||0000-0003-3402-1144
  • López-Vivanco, Guillermo|||0000-0003-3800-6224
  • Del Barco Morillo, Edel|||0000-0001-6443-0585
  • Bernabé, Reyes|||0000-0003-0312-9195
  • Viñolas, Nuria|||0000-0002-8287-2739
  • Barneto Aranda, Isidoro|||0000-0001-6302-1034
  • Viteri, Santiago|||0000-0002-7572-1123
  • Massuti, Bartomeu|||0000-0002-6247-4493
  • Barquín, Miguel
  • Laza-Briviesca, Raquel
  • Sierra Rodero, Belén|||0000-0003-0276-6088
  • Parra, Edwin R.|||0000-0001-9068-1636
  • Sanchez-Espiridion, Beatriz
  • Rocha, Pedro
  • Kadara, Humam
  • Wistuba, Ignacio I.
  • Romero, Atocha|||0000-0002-1634-7397
  • Calvo, Virginia|||0000-0002-3503-4847
  • Provencio Pulla, Mariano|||0000-0001-6315-7919
Purpose: Characterization of the T-cell receptor (TCR) repertoire may be a promising source for predictive biomarkers of pathologic response to immunotherapy in locally advanced non-small cell lung cancer (NSCLC). Experimental Design: In this study, next-generation TCR sequencing was performed in peripheral blood and tissue samples of 40 patients with NSCLC, before and after neoadjuvant chemoimmunotherapy (NADIM clinical trial, NCT03081689), considering their complete pathologic response (CPR) or non-CPR. Beyond TCR metrics, tissue clones were ranked by their frequency and spatiotemporal evolution of top 1% clones was determined. Results: We have found a positive association between an uneven TCR repertoire in tissue samples at diagnosis and CPR at surgery. Moreover, TCR most frequently ranked clones (top 1%) present in diagnostic biopsies occupied greater frequency in the total clonal space of CPR patients, achieving an AUC ROC to identify CPR patients of 0.967 (95% confidence interval, 0.897-1.000; P ¼ 0.001), and improving the results of PD-L1 tumor proportion score (TPS; AUC = 0.767; P = 0.026) or tumor mutational burden (TMB; AUC = 0.550; P = 0.687). Furthermore, tumors with high pretreatment top 1% clonal space showed similar immune cell populations but a higher immune reactive gene expression profile. Finally, the selective expansion of pretreatment tissue top 1% clones in peripheral blood of CPR patients suggests also a peripheral immunosurveillance, which could explain the high survival rate of these patients. Conclusions: We have identified two parameters derived from TCR repertoire analysis that could outperform PD-L1 TPS and TMB as predictive biomarkers of CPR after neoadjuvant chemoimmunotherapy, and unraveled possible mechanisms of CPR involving enhanced tumor immunogenicity and peripheral immunosurveillance.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

GSDMD-dependent pyroptotic induction by a multivalent CXCR4-targeted nanotoxin blocks colorectal cancer metastases

  • Sala, Rita
  • Rioja Blanco, Elisa|||0000-0003-4176-8772
  • Serna, Naroa|||0000-0001-5682-8198
  • Sánchez-García, Laura|||0000-0002-8420-1701
  • Álamo, Patricia|||0000-0003-0510-5701
  • Alba Castellón, Lorena|||0000-0003-3449-7820
  • Casanova Rigat, Isolda|||0000-0002-1196-4724
  • López Pousa, Antonio|||0000-0003-1066-3951
  • Unzueta Elorza, Ugutz|||0000-0001-5119-2266
  • Céspedes, María Virtudes|||0000-0003-2956-5833
  • Vázquez, Esther|||0000-0003-1052-0424
  • Villaverde, Antonio|||0000-0002-2615-4521
  • Mangues, Ramon|||0000-0003-2661-9525
Colorectal cancer (CRC) remains the third cause of cancer-related mortality in Western countries, metastases are the main cause of death. CRC treatment remains limited by systemic toxicity and chemotherapy resistance. Therefore, nanoparticle-mediated delivery of cytotoxic agents selectively to cancer cells represents an efficient strategy to increase the therapeutic index and overcome drug resistance. We have developed the T22-PE24-H6 therapeutic protein-only nanoparticle that incorporates the exotoxin A from Pseudomonas aeruginosa to selectively target CRC cells because of its multivalent ligand display that triggers a high selectivity interaction with the CXCR4 receptor overexpressed on the surface of CRC stem cells. We here observed a CXCR4-dependent cytotoxic effect for T22-PE24-H6, which was not mediated by apoptosis, but instead capable of inducing a time-dependent and sequential activation of pyroptotic markers in CRC cells in vitro. Next, we demonstrated that repeated doses of T22-PE24-H6 inhibit tumor growth in a subcutaneous CXCR4 CRC model, also through pyroptotic activation. Most importantly, this nanoparticle also blocked the development of lymphatic and hematogenous metastases, in a highly aggressive CXCR4 SW1417 orthotopic CRC model, in the absence of systemic toxicity. This targeted drug delivery approach supports for the first time the clinical relevance of inducing GSDMD-dependent pyroptosis, a cell death mechanism alternative to apoptosis, in CRC models, leading to the selective elimination of CXCR4 cancer stem cells, which are associated with resistance, metastases and anti-apoptotic upregulation.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

DNA methylation biomarkers of myocardial infarction and cardiovascular disease

  • Fernández-Sanlés, Alba
  • Sayols-Baixeras, Sergi
  • Subirana, I.
  • Sentí, Mariano
  • Pérez-Fernández, S.
  • de Castro Moura, Manuel
  • Esteller, M|||0000-0003-4490-6093
  • Marrugat, Jaume|||0000-0003-3320-554X
  • Elosua, Roberto|||0000-0001-8235-0095
Background: The epigenetic landscape underlying cardiovascular disease (CVD) is not completely understood and the clinical value of the identified biomarkers is still limited. We aimed to identify differentially methylated loci associated with acute myocardial infarction (AMI) and assess their validity as predictive and causal biomarkers. Results: We designed a case-control, two-stage, epigenome-wide association study on AMI (n = 391, n = 204). DNA methylation was assessed using the Infinium MethylationEPIC BeadChip. We performed a fixed-effects meta-analysis of the two samples. 34 CpGs were associated with AMI. Only 12 of them were available in two independent cohort studies (n ~ 1800 and n ~ 2500) with incident coronary and cardiovascular disease (CHD and CVD, respectively). The Infinium HumanMethylation450 BeadChip was used in those two studies. Four of the 12 CpGs were validated in association with incident CHD: AHRR-mapping cg05575921, PTCD2-mapping cg25769469, intergenic cg21566642 and MPO-mapping cg04988978. We then assessed whether methylation risk scores based on those CpGs improved the predictive capacity of the Framingham risk function, but they did not. Finally, we aimed to study the causality of those associations using a Mendelian randomization approach but only one of the CpGs had a genetic influence and therefore the results were not conclusive. Conclusions: We have identified 34 CpGs related to AMI. These loci highlight the relevance of smoking, lipid metabolism, and inflammation in the biological mechanisms related to AMI. Four were additionally associated with incident CHD and CVD but did not provide additional predictive information.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

A Bocage Landscape Restricts the Gene Flow of Pest Vole Populations

  • Somoano, Aitor|||0000-0002-6055-4334
  • Bastos-Silveira, Cristiane
  • Ventura Queija, Jacinto|||0000-0001-7527-1532
  • Miñarro, Marcos|||0000-0002-5851-6873
  • Heckel, Gerald
The population dynamics of most animal species inhabiting agro-ecosystems may be determined by landscape characteristics, with agricultural intensification and the reduction of natural habitats influencing dispersal and hence limiting gene flow. Increasing landscape complexity would thus benefit many endangered species by providing different ecological niches, but it could also lead to undesired effects in species that can act as crop pests and disease reservoirs. We tested the hypothesis that a highly variegated landscape influences patterns of genetic structure in agricultural pest voles. Ten populations of fossorial water vole, Arvicola scherman, located in a bocage landscape in Atlantic NW Spain were studied using DNA microsatellite markers and a graph-based model. The results showed a strong isolation-by-distance pattern with a significant genetic correlation at smaller geographic scales, while genetic differentiation at larger geographic scales indicated a hierarchical pattern of up to eight genetic clusters. A metapopulation-type structure was observed, immersed in a landscape with a low proportion of suitable habitats. Matrix scale rather than matrix heterogeneity per se may have an important effect upon gene flow, acting as a demographic sink. The identification of sub-populations, considered to be independent management units, allows the establishment of feasible population control efforts in this area. These insights support the use of agro-ecological tools aimed at recreating enclosed field systems when planning integrated managements for controlling patch-dependent species such as grassland voles.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Peripheral Neutrophil-to-Lymphocyte Ratio in Bronchiectasis, A Marker of Disease Severity

  • Martínez García, Miguel Ángel|||0000-0002-7321-1891
  • Olveira, Casilda|||0000-0002-6912-7400
  • Girón, Rosa|||0000-0001-7094-0848
  • García Clemente, Marta|||0000-0003-0463-5946
  • Maíz Carro, Luis|||0000-0003-0547-6238
  • Sibila, Oriol|||0000-0002-4833-6713
  • Golpe, Rafael|||0000-0002-3759-5322
  • Méndez, Raúl|||0000-0001-6300-9836
  • Rodriguez Hermosa, Juan Luis|||0000-0003-0552-2484
  • Barreiro, Esther|||0000-0003-2708-3443
  • Prados, Concepción
  • Rodríguez López, Juan|||0000-0003-0089-9768
  • de la Rosa Carrillo, David|||0000-0003-0753-1771
Most patients with bronchiectasis have a predominantly neutrophilic inflammatory profile, although other cells such as lymphocytes (as controllers of bronchial inflammation) and eosinophils also play a significant pathophysiological role. Easy-to-interpret blood biomarkers with a discriminative capacity for severity or prognosis are needed. The objective of this study was to assess whether the peripheral neutrophil-to-lymphocyte ratio (NLR) is associated with different outcomes of severity in bronchiectasis. A total of 1369 patients with bronchiectasis from the Spanish Registry of Bronchiectasis were included. To compare groups, the sample was divided into increasing quartiles of NLR ratio. Correlations between quantitative variables were established using Pearson's P test. A simple linear regression (with the value of exacerbations as a quantitative variable) was used to determine the independent relationship between the number and severity of exacerbations and the NLR ratio. The area under the curve (AUC)-ROC was used to determine the predictive capacity of the NLR for severe bronchiectasis, according to the different multidimensional scores. Mean age: 69 (15) years (66.3% of women). The mean NLR was 2.92 (2.03). A higher NLR was associated with more severe bronchiectasis (with an especially significant discriminative power for severe forms) according to the commonly used scores (FACED, E-FACED and BSI), as well as with poorer quality of life (SGRQ), more comorbidities (Charlson index), infection by pathogenic microorganisms, and greater application of treatment. Furthermore, the NLR correlated better with severity scores than other parameters of systemic inflammation. Finally, it was an independent predictor of the incident number and severity of exacerbations. In conclusion, the NLR is an inexpensive and easy-to-measure marker of systemic inflammation for determining severity and predicting exacerbations (especially the most severe) in patients with bronchiectasis.